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The immune response to an invading pathogen must be tightly regulated so as to 
combat the infection while avoiding immune-mediated pathologies. This requires the 
coordinated response of both innate and adaptive immunity, involving an array of cell 
types, including T cells, macrophages, and dendritic cells. While many studies have 
examined the general host immune response to infection, this thesis aimed to more 
clearly dissect the roles of the chemokine receptor CXCR3 and β-catenin in the 
coordination of this complex response by T cells and dendritic cells, respectively. 
 
I show that CXCR3 expression is required on CD4+ T cells for efficient clearance of 
the protozoan parasite Toxoplasma gondii during the intestinal response to infection. 
In the absence of this receptor, impaired CD4+ T cell-dependent IFN-γ renders 
intestinal inflammatory monocytes inactive, and mice succumb to intestine-restricted 
overgrowth of parasite. 
 
Tissue resident dendritic cells are the first immune cells to recognize foreign antigen 
and are crucial to the initiation of adaptive immunity. I show that differentiation of 
CD8α+ and related CD103+ tissue resident DC subsets is positively regulated by β-
catenin signaling, a pathway normally associated with tumorigenesis. Constitutive β-
catenin signaling in DC thus leads to susceptibility of mice to Toxoplasma gondii 
 infection by excessively promoting proinflammatory DC subsets in dependence on 
interferon regulatory factor (IRF) 8 expression, resulting in hyperactivation of CD4+ T 
cells. 
 
Interestingly, I show that β-catenin signaling in bone marrow-derived DC (BMDC) 
displays the reverse phenotype, whereby antigen-specific T cell activation and 
cytokine production are impaired by these DC. This finding underscores the 
phenotypic and genetic variation among different DC subsets and that β-catenin has 
the capacity to promote both inflammatory and tolerant DC subsets depending on 
context.  
 
The data in this thesis provide novel insight into the mechanisms of immune cell 
trafficking, signaling, and differentiation, which ultimately lead to host protection 
against microbial insult.  
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CHAPTER 1 
 
Introduction to Toxoplasma gondii, monocytes, dendritic cells,  
and Wnt signaling 
	   	  
	   2	  
Toxoplasma gondii 
Toxoplasma gondii is an obligate intracellular protozoan parasite within the 
Apicomplexa phylum. It was simultaneously discovered by Charles Nicolle and Louis 
Manceaux in Tunis and by Alfonso Splendore in Brazil in 1908 (1). It was ultimately 
discovered that T. gondii sexual reproduction can occur only in the intestinal tract of 
members of the cat family, and all other hosts, including rodents and people, are 
intermediate hosts (Figure 1.1) (2-4). As major prey of cats, rodents are a primary 
natural intermediate host of T. gondii, and they therefore serve as excellent 
experimental models for its study. Among people, seropositivity of T. gondii varies by 
region from 10-80%, but within the United States it nears 11% (5, 6). Most infections 
are asymptomatic, but in immunocompromised individuals, particularly AIDS patients, 
infection can be fatal. The most common symptom is encephalitis, and during the peak 
of the AIDS epidemic in the early 1990s, an estimated 10% of patients in the US died 
annually from this complication (7). However, the number of AIDS-associated 
toxoplasmic encephalitis cases dropped 3-fold to only 3,643 cases by 2001 as a result 
of improved anti-retroviral therapies (8). 
Toxoplasmosis may also be acquired congenitally if the mother becomes infected for 
the first time during pregnancy. The earlier in pregnancy the infection occurs, the 
more severe the disease outcome, with the most common symptoms being 
retinochoroiditis, hydrocephalus, and ocular disease. The other major routes of 
transmission are ingestion of tissue cysts from undercooked meat, oocysts from food 
or water contaminated by cat feces, or organ transplants and blood transfusions from 
infected donors (5). Within immunocompetent hosts, the most frequent symptom is 
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lymphadenopathy, and infection generally goes unnoticed. T. gondii has many features 
in common with other disease-causing protozoans, including Plasmodium, 
Trypanosoma, and Leishmania (9). Therefore, understanding the immune response of 
a ubiquitous and potentially fatal pathogen such as T. gondii can provide insight into 
the immune response to other diseases of public health importance.  
T. gondii is the sole species within the Toxoplasma genus and is sorted into 3 distinct 
clonal lineages based on allelic variation. In mice, these lineages vary in virulence, 
with type I being the most virulent and types II and III being less virulent (10). T. 
gondii is unique among other Apicomplexans in that it can infect any warm-blooded 
animal. Upon ingestion of oocysts or tissue cysts, sporozoites or bradyzoites, 
respectively, excyst and penetrate the intestinal epithelium, converting into fast 
replicating tachyzoites (11). Cell invasion by tachyzoites is an active process 
involving the parasite secretory organelles micronemes, rhoptries, and dense granules. 
During invasion, these organelles release their contents to form a moving junction 
with the host plasma membrane, where they then enter the host cell and manipulate 
host signaling cascades (12-18). The parasite resides in the subsequently formed 
parasitophorous vacuole (PV) that excludes all but GPI-anchored host proteins. This 
structure acts as a molecular sieve by allowing passive diffusion of molecules ≤1400 
Daltons for nutrient acquisition, yet protecting T. gondii from degradation as it 
remains segregated from host endocytic and exocytic pathways (19, 20). The timing 
and location of parasitophorous vacuole formation appears to be strain-specific, as 
Type I parasites form a moving junction at the plasma membrane upon active host cell 
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invasion, whereas avirulent Type II parasites form a moving junction from within the 
phagosome following phagocytic uptake (21). 
General immune response to Toxoplasma gondii 
Toxoplasma mounts a potent cell-mediated immune response that involves the 
cooperation of multiple components of the host immune system. Unless the host is 
immunocompromised upon infection, this immune response is sufficient to protect 
from overt disease, and the parasite is forced into a quiescent cyst stage, where it can 
remain for the duration of the life of the host (22). Protective immunity is dependent 
on the proinflammatory cytokines IL-12 and IFN-γ, as the absence of either can lead 
to rapid death of the host at the acute phase of T. gondii infection (23, 24). IL-12 can 
be produced by dendritic cells, macrophages, and neutrophils (25-28), and this IL-12 
serves to activate a Th1 program in CD4+ and CD8+ T cells as well as natural killer 
(NK) cells, leading to the secretion of high levels of IFN-γ (Figure 1.2) (22, 29-31).  
The requirement for IFN-γ in host defense against T. gondii has long been recognized 
(32). Early studies identified a role for IFN-γ in activating microbicidal functions in 
macrophages, such as upregulation of reactive oxygen intermediates and the 
tryptophan degrading enzyme indoleamine dioxygenase (IDO), leading to parasite 
elimination in vitro and during chronic infection (33, 34). More recent studies argue 
that IFN-γ signaling activates immunity-related GTPases (IRG) that disrupt the 
parasitophorous vacuole in which the parasite resides, leading to its elimination from 
the host cell (35-37). Interestingly, IRG proteins are not expressed by humans, leading 
to fascinating questions about the undetermined role of IFN-γ in host protection 
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against T. gondii in humans as well the evolutionary relationships between 
Toxoplasma, humans, and other intermediate hosts of infection (38). 
The natural route of Toxoplasma infection is peroral, and the initial site of infection is 
therefore the gut. The mucosal immune response is specially equipped to combat such 
infections, and the nature of this response is discussed in detail in Chapter 2. 
Importantly, two of the first cell types to recognize and respond to T. gondii are those 
lying within the monocyte/macrophage and dendritic cell lineages. 
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Figure 1.1 Life cycle of Toxoplasma gondii. (1) Members of the cat family shed 
oocysts through their feces, and these oocysts sporulate in the environment to become 
infectious, each containing 2 sporocysts with 4 sporozoites. Intermediate hosts, such 
as rodents, ingest these cysts in the environment, releasing tachyzoites that convert to 
life-long tissue cysts. Cats can become reinfected through (2) carnivorism of rodents 
harboring tissue cysts or (3) through direct ingestion of sporulated oocysts, and sexual 
reproduction of the parasite can again occur within the feline small intestine. Humans 
are incidental hosts that can be infected through (4) ingestion of undercooked meat 
from intermediate hosts harboring tissue cysts, such as pork products, or (5) ingestion 
of vegetable products that have been contaminated with oocysts. (6) Other 
mechanisms of human transmission include vertical transmission from infected 
pregnant mother to fetus and horizontal transmission via donation of contaminated 
blood or tissue, such as during blood transfusion or organ transplantation. 
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Figure 1.2 General immune response to Toxoplasma gondii. (1) Initial parasite 
recognition is mediated by innate immune cells, including dendritic cells, 
macrophages, and neutrophils. (2) TLR-dependent recognition of parasite results in 
the secretion of IL-12. (3) IL-12 activates natural killer cells and T cells to produce 
IFN-γ. (4) IFN-γ signaling is key for the activation of antimicrobial effector cells, 
including inflammatory monocytes, which eliminate the parasite via mechanisms 
including reactive oxygen intermediates, immunity-related GTPase induction, and 
tryptophan degradation.  
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Role of monocytes and macrophages during Toxoplasma infection 
Blood monocytes emerge from the bone marrow as precursors of macrophages and are 
recruited to tissues in response to infection-induced chemokines, where they take on 
the name inflammatory monocyte and are distinguished by expression of Ly6C, TNF-
α, and iNOS (Figure 1.3) (39). They are frequently infected in vivo upon T. gondii 
infection and are a source of protective IL-12 (40-42). Furthermore, they are required 
for protection against T. gondii, as mice with impaired emigration of monocytes from 
the bone marrow are highly susceptible to infection (41, 43). T. gondii has acquired 
multiple mechanisms to subvert macrophage function, including inhibition of cytokine 
production, altered chromatin remodeling at IFN-γ-responsive promoters, and 
inactivation of IRG molecules (12, 13, 44, 45). Macrophages clearly play a significant 
role in immunity during T. gondii infection, and further details regarding this role are 
discussed in Chapter 2. 
Dendritic cell subsets and function 
Dendritic cells (DC) are unique innate immune cells that, in addition to recognizing 
and responding to foreign antigen, initiate adaptive immunity through antigen 
presentation (46). DC originate from a common dendritic progenitor in the bone 
marrow and can later be subdivided into tissue-resident conventional DC (cDC), 
plasmacytoid DC (pDC), dermal-resident Langerhans DC, and monocyte-derived DC 
(moDC). These subsets are distinguished by surface marker expression, transcription 
and growth factor requirements, tissue distribution, and function (Figure 1.3). For 
example, splenic CD8α+ DC depend on IRF8, Id2, Batf3, and Nfil3 and are 
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considered efficient cross-presenting DC (47-51), while splenic CD4+ DC require 
IRF4 expression and more effectively activate MHCII-restricted CD4+ T cells (52). 
Conversely, pDC are poor antigen presenters yet secrete high levels of type I IFN 
following viral infection, and they require IRF8, STAT3, and E2-2 for differentiation 
(53, 54).  
The CD8α+ DC subset is particularly crucial for the immune response to Toxoplasma 
gondii infection, as genetic deletions of CD11c or the CD8α+ DC transcription factor 
Batf3 result in susceptibility to infection associated with impaired IL-12 secretion (55-
57). Details of the role of DC during toxoplasmosis are discussed in Chapter 2. 
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Figure 1.3 Differentiation and function of dendritic cell subsets and macrophages. 
(1) Monocyte-derived DC (moDC) differentiate from blood monocytic precursors 
following inflammatory signals that recruit them into the tissue. There they upregulate 
TNF-α and iNOS and are key effectors against intracellular pathogens. (2) Precursors 
of DC (pre-DC) upregulate transcription factors upon entry into tissues, including 
interferon regulatory factors (IRF) 4 and 8, which direct conventional DC (cDC) 
subsets that antigen present and produce IL-12. (3) Plasmacytoid DC (pDC) 
differentiate directly from common dendritic progenitors in the bone marrow based on 
expression of transcription factors E2-2, STAT3, and IRF8, and they are key 
responders to viral infections due to their strong capacity to secrete type I IFN. 
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Figure 1.4 Overview of the Wnt signaling pathway. The Wnt pathway centers 
around the transcription factor β-catenin, which is normally phosphorylated by a 
complex containing glycogen synthase kinase (GSK)-3β, Axin, and adenomatous 
polyposis coli (APC), leading to its proteasomal degradation. (1) Upon Wnt ligand 
binding to Frizzled (Fzd) receptors, phosphorylation of β-catenin is inhibited due to 
recruitment of Axin to the low density lipoprotein receptor-related protein (LRP) at 
the cell membrane, thus (2) disassociating the destruction complex. (3) β-catenin then 
accumulates in the cytoplasm and subsequently translocates to the nucleus. (4) There, 
it activates a wide array of transcriptional programs in conjunction with its co-factors 
T cell factor/lymphoid enhancer factor (TCF/LEF). 
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Role of Wnt signaling in dendritic cell programming 
Wnt signaling is an essential physiological pathway, as its deletion results in 
embryonic lethality, and activating mutations are often oncogenic (58, 59). The Wnt 
pathway centers around the transcription factor β-catenin, whose cytoplasmic levels 
are tightly regulated by continual phosphorylation, which results in its proteasomal 
degradation. Wnt ligand binding to cell surface Frizzled receptors inhibits this 
phosphorylation, resulting in the cytoplasmic accumulation and nuclear translocation 
of β-catenin, where it activates an array of target genes (Figure 1.4). Example 
transcriptional targets of β-catenin include genes related to proliferation, apoptosis, 
survival, and stem cell renewal (60-62). More recently, Wnt signaling has been 
recognized for its role in hematopoiesis and immunity (63), and this role has been 
extended to dendritic cell development and function. Activating Wnt signals during 
DC development from bone marrow precursors can enhance DC differentiation and 
maturation (64), and maturation of bone marrow-derived DC (BMDC) by cluster 
disruption activates β-catenin signaling, promoting an anti-inflammatory phenotype 
that is protective against experimental autoimmune encephalitis (EAE) (65). 
Furthermore, genetic deletion of β-catenin from CD11c+ cells results in the emergence 
of a proinflammatory phenotype in small intestinal T cells, suggesting a role for β-
catenin in promoting tolerance in the intestine (66). Therefore, it is has become 
increasingly accepted that β-catenin signaling plays a role in controlling DC function 
both in vivo and in vitro, and the consensus is that β-catenin promotes tolerizing 
signals to DC. 
	   14	  
Outline of dissertation research 
The host immune response to infection requires a tightly regulated balance between 
the generation of proinflammatory cells to combat invading pathogens and anti-
inflammatory cells to prevent potentially harmful immune activation. The 
simultaneous coordination of these events is a highly complex process involving cells 
of both the innate and adaptive arms of the immune system. The aim of this 
dissertation was to examine several of these facets of host immunity both during 
homeostasis as well as during infection with the protozoan parasite Toxoplasma gondii.  
Chapter 2 provides a discussion of the currently available data regarding the intestinal 
immune response following oral infection with T. gondii. In line with mucosal 
immunity, Chapter 3 assesses the role of chemokine receptor CXCR3 in the 
establishment of protective immunity against T. gondii following natural peroral 
infection. This study identifies CXCR3 as required for the optimal trafficking of CD4+ 
T cells to the small intestine to secrete IFN-γ, thus activating inflammatory monocytes 
to eliminate parasite in the gut. In the absence of CXCR3, mice succumb at the acute 
phase of infection in association with overgrowth of parasite in the small intestine, 
impaired T cell IFN-γ and monocyte IL-12, and influx of pathogenic TNF-α-secreting 
neutrophils to the gut.  
My interest in β-catenin stemmed from the finding that it promotes tolerance in the 
intestine (66), and I hypothesized that constitutive DC β-catenin signaling would 
protect mice from the lethal inflammatory bowel-like phenotype that results from high 
dose T. gondii infection (67). As seen in Chapter 4, mice with constitutive β-catenin 
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signaling in DC are equally susceptible to high dose infection and are more susceptible 
to low dose infection. This susceptibility phenotype is due to β-catenin-dependent 
IRF8 upregulation, leading to the expansion of splenic CD8α+ DC that hypersecrete 
IL-12 upon stimulation with Toxoplasma or LPS despite increased regulatory T cell 
induction. This study identifies a novel role for β-catenin in tissue resident DC 
differentiation and activation. 
In Chapter 5, the effect of β-catenin signaling on BMDC and tissue resident splenic 
DC was compared. Interestingly, BMDC acquired a largely anti-inflammatory 
phenotype upon β-catenin activation, as IL-12 secretion was reduced following 
stimulation, and antigen-specific BMDC-dependent CD4+ T cell proliferation was 
strongly impaired. We conclude that different DC subsets are differentially affected by 
β-catenin signaling, potentially due to differences in the availability of target gene 
promoters or transcription factors.  
Finally, the significance of these findings and how they serve to better our 
understanding of host immunity in the face of microbial infection is described in 
Chapter 6. Future directions for continuation of these projects are also discussed. 
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Abstract 
Toxoplasma gondii is a highly prevalent protozoan pathogen that is transmitted 
through oral ingestion of infectious cysts. As such, mucosal immune defenses in the 
intestine constitute the first and arguably most important line of resistance against the 
parasite. The response to infection is now understood to involve complex three-way 
interactions between Toxoplasma, the mucosal immune system and the host intestinal 
microbiota. Productive outcome of these interactions ensures resolution of infection in 
the intestinal mucosa. Nonsuccessful outcome may result in emergence of 
proinflammatory damage that can spell death for the host. Here, we discuss new 
advances in our understanding of the mechanisms underpinning these disparate 
outcomes, with particular reference to initiators, effectors and regulators of mucosal 
immunity stimulated by Toxoplasma in the intestine. 
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Introduction 
The intestinal mucosa forms a dynamic arena in which principles of tolerance and 
immunity are dramatically played out throughout the host lifetime (1-3). Effective 
responses maintain homeostasis and protect from infection, but dysregulated immunity 
can lead to inability to control microbial incursion and may lead to chronic 
inflammatory disease in the gut mucosa and beyond (4-6). 
 
The structure of the intestine sets the landscape within which these fundamentals of 
mucosal immunology are played out. The intestinal mucosa is composed of a single 
layer of epithelial cells with an embedded population of nonconventional 
intraepithelial lymphocytes. Underlying this, the lamina propria (LP) contains diverse 
cell types responsible for defense against invading pathogens, including T cells, 
macrophages and dendritic cells (DC), as well as those that maintain tolerance to 
commensal flora in the gut. Within the intestinal lumen itself, the vast number of 
commensals (on the order of 1014 in humans, with several thousand discrete species 
normally present) underscores the astounding ability to detect and respond to 
incoming pathogens while simultaneously avoiding inappropriate reactions to 
harmless or even beneficial occupants of the intestine. Studies largely in mice with the 
orally acquired protozoan parasite Toxoplasma gondii have served to illuminate these 
principles and have contributed key insights into inflammation and immunity in the 
intestinal mucosa during infection.    
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Toxoplasma is an exceedingly common parasite of humans and animals, and it is 
estimated that 10-50% of the human population are latently infected with the parasite 
worldwide. The vast majority of cases are asymptomatic, but the parasite may emerge 
as a life-threatening opportunistic pathogen in immunodeficient hosts and during 
congenital infection (7). Infection is acquired by ingestion of tissue cysts or oocysts 
shed by cats. Within the small intestine, T. gondii differentiates into the fast 
replicating and disseminating form known as the tachyzoite (8). Invasion of host cells 
by tachyzoites results in creation of a specialized parasitophorous vacuole within 
which Toxoplasma replicates, eventually leading to egress and entry into new host 
cells. Infection leads to spreading beyond the intestinal mucosa and culminates in cyst 
formation within skeletal muscle and central nervous system tissues. Within the latter 
tissue, toxoplasmic encephalitis may emerge as a life-threatening disease in 
immunosuppressed patients. In the feline intestine, the parasite undergoes sexual 
reproduction, resulting in fecal shedding of highly infectious oocysts into the 
environment. T. gondii is known for its ability to induce a strongly polarized Th1 
response that is normally highly effective in host protection but that can also spiral out 
of control to cause host tissue damage and sometimes death (9-11). Although 
Toxoplasma spreads well beyond the borders of the intestinal mucosa, it is within this 
tissue that the first encounter between the parasite and host immune system occurs. As 
such, the mucosal immune response is key to determining the outcome of infection 
with this microbial pathogen.         
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Early mucosal targets of infection  
In order to establish successful infection, Toxoplasma must breach the intestinal 
epithelial layer, after which it must disseminate and convert to the life-long latent 
form. Although tachyzoites may directly invade intestinal epithelial cells, in vitro 
studies employing polarized intestinal cell lines suggest the parasites use a more 
efficient transmigration mechanism dependent on a paracellular pathway. This 
pathway involves manipulation of host cell intercellular cell adhesion molecule 
(ICAM)-1 and occludin to pass through cellular tight junctions (12, 13). Interestingly, 
transmigratory capability seems to be genetically controlled in Toxoplasma and is 
linked to virulence of the parasite (14, 15). 
 
Once through the epithelial barrier, T. gondii invades numerous cell types within the 
small intestinal LP. Parasites genetically engineered to express fluorescent markers 
were used to identify infected LP cells after infection, where monocytes and 
neutrophils were identified as the most frequently infected cells, followed by 
macrophages and lymphocytes, while dendritic cells (DC) comprised a low percentage 
of the infected population (16, 17). T. gondii forms discrete foci of replication within 
small intestinal villi, and two recent studies provide unexpected evidence that this 
occurs because the parasite travels in retrograde fashion through the intestinal lumen 
rather than the tissue to establish localized centers of infection. Interestingly, it also 
appears to be the case that infected LP neutrophils may transmigrate into the lumen to 
establish new infection foci (16, 17). A related role for retrograde neutrophil 
transmigration in the response to Toxoplasma comes from a recent study showing that 
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neutrophils emigrate into the intestinal lumen shortly after infection to form structures 
that encapsulate commensals, limiting their entry into the intestinal mucosa that would 
otherwise occur (18, 19).  
 
Dendritic cells are well known for their capacity to take up soluble or particulate 
antigen and migrate to regional lymphoid organs. As such, they have also been 
proposed to be “Trojan horses” for parasite dissemination during oral and 
intraperitoneal infection (20, 21). Interestingly, DC infected with T. gondii acquire a 
hypermotility phenotype that is dependent upon parasite exploitation of GABAergic 
signaling in the host cell (22, 23). Adoptive transfer of infected DC results in faster 
parasite dissemination and increased parasite burden compared to transfer of free 
parasites (24). However, it has yet to be established that this phenomenon also 
operates in the intestinal mucosa. Regardless, while some studies indicate that LP DC 
are not a major infection reservoir, they may nevertheless contribute to dissemination 
of parasites from the mucosa into regional lymph nodes and beyond.  
 
Role of mucosal dendritic cells in innate immune initiation 
Concomitant with early invasion in the intestinal mucosa, it is essential for host 
resistance that IL-12 production is initiated to ensure production of protective IFN-
γ by NK cells and newly generated Th1 T lymphocytes. Several studies have 
characterized cellular sources of IL-12 following oral T. gondii infection. While in 
vitro studies identify neutrophils, dendritic cells and inflammatory monocytes as cells 
that produce IL-12 in response to T. gondii, the relative role of these cells during in 
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vivo infection is less clear (25-28). While neutrophils may be an important in vivo 
source of IL-12 stimulating protective immunity, more current data indicate that 
neutrophil recruitment to the intestine contributes to small intestinal inflammatory 
pathology that is triggered by Toxoplasma (29, 30).    
 
Dendritic cells are implicated as a primary source of IL-12 based upon i.p. and oral 
infection studies using the Cre-flox and diphtheria toxin systems, respectively, to 
delete  cells expressing CD11c, a marker associated with DC (25, 31). In the case of 
oral infection, ablation of CD11c+ cells leads to elevated parasite burden and loss of 
the CD4+ T cell IFN-γ response. An important caveat in these studies is that CD11c 
can also be expressed by inflammatory monocytes, which themselves are observed to 
produce IL-12 during infection (29, 30, 32). Nevertheless, mice lacking Batf3, a 
transcription factor important for differentiation of CD8α and tissue CD103 DC (33, 
34), are defective in IL-12 production during Toxoplasma infection, providing 
compelling evidence for these specific DC subsets as sources of IL-12 during oral 
infection (35). Amongst these, CD103 DC may be the prime IL-12 source in the 
intestinal mucosa, as a previous study showed that intestinal CD8α-, but not CD8α+ 
DC, express IL-12 following oral infection (18).  
 
A recent study employed diphtheria toxin to ablate cells expressing a newly identified 
transcription factor zDC (Zbtb46, Btbd4), which is exclusively expressed by 
conventional DC subsets and not by monocytes or plasmacytoid DC (pDC) (31). Mice 
that were ablated for these cells and then orally infected with T. gondii failed to reach 
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the same level of susceptibility and reduced Th1 activity as CD11c-depleted mice. 
This suggests that non-conventional DC or other cells that express CD11c, possibly 
including inflammatory monocytes, may also contribute to establishment of protective 
immunity to T. gondii (31). One scenario that seems particularly likely is that resident 
CD103+ DC in the intestine provide the initial burst of IL-12, and this is followed by 
activation and recruitment of inflammatory monocytes to the intestinal mucosa that 
might further contribute to the IL-12 response during infection, enabling optimal Th1 
generation. 
 
In addition to producing IL-12, mucosal DC have been shown to regulate T cell 
responses following T. gondii infection by production of the vitamin A metabolite 
retinoic acid (RA). Production of RA by mucosal DC promotes tolerogenic responses 
at steady-state by acting in concert with TGF-β to induce mucosal Treg (36-38). 
Because RA directly binds to T cells via RA receptor (RAR)-α and enhances T cell 
receptor signaling (39), more generalized effects of RA on T cells are possible. 
Indeed, loss of RAR-α signaling in the context of inflammation initiated by 
Toxoplasma infection results in defective T cell effector responses in the mucosal 
compartment and increased susceptibility to the parasite (39). 
 
Immune recognition  
How T. gondii is detected by the immune system and the role of Toll-like receptors 
(TLR) in this lynchpin event has been the subject of intense interest and investigation 
(40-42). Mice deficient in MyD88 and IRAK4, central mediators of TLR signaling, 
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are extremely susceptible to Toxoplasma infection (43-45). Furthermore, deficiency in 
UNC93B, a chaperone protein involved in trafficking intracellular TLR from the 
endoplasmic reticulum to the endosomal compartment, results in complete loss of 
resistance to T. gondii (46, 47). These results together point to intracellular TLR as 
being particularly important in immune detection of Toxoplasma.  
 
The tachyzoite protein profilin (TgPRF) serves as an IL-12-inducing ligand for 
TLR11, which along with TLR3, 7, 8, 9 and 12, is expressed intracellularly (47, 48). 
More recently, it was found that TgPRF also activates immunity through binding to 
TLR12 (49-51). Current evidence indicates that TgPRF recognition by TLR11 or 
TLR12 homodimers or TLR11/12 heterodimers is a major event in innate immune 
recognition of Toxoplasma. Which particular TLR configuration takes primary 
importance may depend upon the cell type involved or the context of infection. While 
this is an area that has yet to be explored in detail, results in Tlr11-/- mice indicate that 
signaling mediated by this receptor plays a role in proinflammatory Crohn’s disease-
like pathology in the intestine that is triggered by high dose infection (18).    
 
Tachyzoite profilin is a molecule that is required for cell invasion (52). As a molecule 
essential for parasite survival, it fulfills a basic requirement for a pathogen-associated 
molecular pattern targeted for recognition by the immune system (53). The TgPRF 
protein is not actively secreted by Toxoplasma, and TLR11/12 do not observably 
traffic to the parasitophorous vacuole membrane. Therefore, it is most likely that 
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recognition at this level involves DC phagocytic uptake of dead parasites or debris, 
and indeed there is evidence that most IL-12 is produced by noninfected cells (54).  
 
In addition to recognition of TgPRF by intracellular TLR, parasite nucleic acid 
recognition by TLR3, 7 and 9 also facilitates resistance to infection (49). Furthermore, 
TLR2 and TLR4 recognition of parasite glycosylphosphatidylinositol lipids at the cell 
surface may contribute to innate immune activation, although conclusions from these 
studies rely mostly on in vitro observations (55, 56). Regardless, the sum of these data 
strongly argues that several TLR, most prominently TLR11 and TLR12, act in concert 
to signal recognition of T. gondii. Yet, TLR11 and TLR12, while expressed in rodents, 
are absent in many species, including humans. In such cases, TgPRF is most likely 
less important, and other parasite molecules are likely to take the role of primary 
innate immunity triggers. It is possible that parasite nucleic acids and 
glycosylphosphatidylinositol lipids emerge as dominant TLR ligands in these cases.  
 
The secretory dense granule protein GRA15, a molecule expressed in a parasite strain-
dependent manner by low virulence Toxoplasma, has been shown to trigger NFkB 
activation and subsequent IL-12 production directly within infected cells (57). This is 
at odds with data indicating that Toxoplasma is recognized at a distance by 
noninfected cells, but some studies do in fact indicate that IL-12 is produced by 
infected cells (58). One recently proposed model that resolves the apparent 
discrepancy is that IL-12 at earliest points of infection may be produced by infected 
cells through GRA15, and later with the onset of fulminant infection, TgPRF uptake 
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and TLR stimulation in noninfected cells assumes the major source of IL-12 (59). 
Nevertheless, the strain-specificity of GRA15 expression would indicate that the 
cellular origins of IL-12 production must depend upon the infecting Toxoplasma 
isolate.  
 
Luminal bacteria and Toxoplasma together control mucosal immunity during 
infection  
Our understanding of innate immune recognition of Toxoplasma has outpaced similar 
knowledge of other eukaryotic microorganisms. Nevertheless, it has become clear that 
our understanding remains incomplete insofar as simultaneous recognition of luminal 
gut flora must also be considered. Commensal bacteria benefit the host by shaping 
mucosal immunity under steady-state conditions, but they also cause inflammation 
under disequilibrium situations. In the context of Toxoplasma in the intestine, the host 
microbiota plays similar roles.  
 
Data pointing to the importance of the microbiota in oral T. gondii infection come 
from several lines of evidence. Following i.p. infection, TLR11 deficiency results in 
complete loss of DC-derived IL-12 and the subsequent IFN-γ response upon systemic 
T. gondii infection, and mice fail to control the infection, resulting in early mortality. 
Yet, these responses, while diminished, are nevertheless retained in the intestinal 
mucosa of Tlr11-/- mice during mucosal infection, which is in direct contrast to 
infection in MyD88-/- animals. Furthermore, antibiotic treatment of Tlr11-/- animals 
prior to T. gondii infection abolishes the remaining IL-12 and Th1 responses and 
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increases susceptibility to oral infection, demonstrating the importance of gut bacteria 
in providing an immunostimulatory role in the absence of TgPRF recognition (18). 
Thus, the gut commensal population acts as an adjuvant facilitating development of an 
optimal protective immune response to Toxoplasma.   
 
It was recently shown that oral infection with T. gondii directs an antigen-specific 
immune response not only against the parasite, but also against the microbiota itself. 
Through use of mice genetically engineered to express a T cell receptor specific for 
commensal-derived flagellin, Hand et al. showed that a population of CD4+ T cells 
induced by T. gondii infection respond directly to bacterial flagellin through 
proliferation and Th1 differentiation. Surprisingly, the commensal-specific T cell 
population is comparable to that of the parasite-specific cells both in size and 
behavior. Furthermore, these flagellin-specific cells develop into functional memory 
cells (60). T. gondii infection in the gut therefore seems to trigger loss of tolerance to 
intestinal bacteria, possibly due to infection-induced epithelial damage and consequent 
bacterial translocation. In turn, this results in T cell priming against bacterial antigens, 
but the bacteria also provide a source of PAMPs that facilitate ignition of the 
protective Th1 response against Toxoplasma itself (Figure 2.1). 
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Figure 2.1. Gut commensal bacteria serve as adjuvants and antigens for 
Toxoplasma triggered IL-12 and Th1 induction. (1) Gut resident CX3CR1+ 
macrophages and dendritic cells (DC) continually sample bacterial antigens from the 
intestinal lumen by extending dendrites between epithelial cells. (2) Mucosal DC may 
also sample bacteria that have translocated to the LP as a result of Toxoplasma-
mediated disruption of the epithelial barrier associated with infection. This may occur 
during parasite paracellular migration or by direct infection and lysis of epithelial 
cells. (3) DC acquire Toxoplasma antigen either by direct infection or by uptake of 
parasite material. (4) Activated antigen-bearing DC migrate to the draining lymph 
node and produce IL-12, resulting in the activation of Th1 cell populations specific for 
commensals and T. gondii itself.  
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It is also clear that gut bacteria can exacerbate T. gondii infection in a manner that is 
similar to that thought to occur in inflammatory bowel disease (IBD) pathogenesis (5). 
High dose oral infection with T. gondii leads to an IBD-like phenotype in C57BL/6 
mice, which is associated with CD4+ T cell infiltration and overexpression of 
proinflammatory cytokines, including IFN-γ, IL-12 and TNF-α, as well as IL-22 and 
possibly IL-17 (although this is controversial) (61-66). Additionally, T. gondii alters 
the composition of the gut microbiota, resulting in a global reduction in bacterial 
diversity, a switch from Gram-positive to Gram-negative bacteria and an expansion of 
adherent and invasive pathobionts that results in translocation into the LP (67, 68).  
 
It is clear that imbalances in the intestinal microbiota are a cause of inflammation 
during T. gondii infection. For example, administration of antibiotics prior to 
Toxoplasma infection protects mice from parasite-induced ileitis, and gnotobiotic mice 
are resistant to parasite-induced ileitis, confirming the role of the microbiota in 
promoting intestinal lesions upon T. gondii infection (67). Mice deficient for TLR4 
display decreased IFN-γ and NO levels in the small intestine and are more resistant to 
infection, most likely resulting from lost recognition of bacterial TLR4 ligands (68). 
Furthermore, antibiotic treatment of recipient mice protects against ileitis induced by 
adoptive transfer of pathogenic LP CD4+ T cells and IEL from Toxoplasma-infected 
animals (69). These collective studies emphasize the dual potential role of luminal 
microbiota in stimulating protective immunity with low dose parasite inocula versus 
switching to driving an inflammatory cytokine storm that surrounds high dose 
infection.  
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The precise trigger provided by T. gondii that results in loss of tolerance to gut flora 
and intestinal dysbiosis has remained enigmatic, but recent studies suggest that 
parasite effects on Paneth cells may be the key to pathogenesis. Paneth cells are 
specialized epithelial cells located in intestinal crypts, and they secrete antimicrobial 
peptides such as defensins into the intestinal lumen (70). One study found that, early 
after oral infection, Paneth cells degranulate in a TLR9-dependent manner, resulting in 
the release of antimicrobial Criptidins that somehow promote optimal Th1 responses 
to the parasite (71). More directly related to the onset of inflammation, it was recently 
found that Toxoplasma infection causes loss of Paneth cells, an event that in turn leads 
to dysbiosis and fulminant pathology (72). Interestingly, germ-free mice infected with 
T. gondii retain Paneth cells, although they are again eliminated upon the addition of 
Enterobacteriaceae, but not Bacteroides. This suggests that Paneth cell loss is 
dependent on the combined effect of the parasite and Protoeobacteria that emerge as 
dominant species during intestinal inflammation. Loss of Paneth cells is dependent on 
CD4+ T cell IFN-γ production via T cell-intrinsic MyD88 signaling, as Lck-Cre 
Myd88fl/fl mice phenocopy Myd88-/- animals, which display unaltered Paneth cells and 
antimicrobial peptide expression (72). Thus, this study provides a model to understand 
how Toxoplasma triggers inflammation-mediated dysbiosis in the intestine. Early IL-
12-dependent induction of Th1 cells specific for Toxoplasma and intestinal flora 
causes IFN-γ-dependent Paneth cell depletion. In turn, loss of a major source of 
antimicrobial peptides in the small intestine results in overgrowth of pathobionts 
associated with dysbiosis and associated inflammatory lesions (Figure 2.2). This has  
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particular relevance for understanding ileal Crohn’s pathogenesis because independent 
studies have implicated dysfunctional Paneth cell responses as underlying onset of 
disease (73). 
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Figure 2.2. Control of infection and emergence of dysbiosis during Toxoplasma 
infection. (1) IFN-γ produced by Th1 lymphocytes and NK cells (not shown) induces 
killing of parasites and resolution of infection. The degree to which parasite- and 
commensal-specific T cells (denoted in yellow and green) contribute to killing is 
presently unclear. (2) During emergence of dysbiosis, infection-induced IFN-γ 
promotes Paneth cell elimination. Normally, these cells secrete antimicrobial peptides 
(AMP) into the intestinal lumen to maintain homeostatic levels of commensal 
populations, including the healthy Gram-positive Bacteroides (shown in yellow). (3) 
Expansion of pathogenic Gram-negative Enterobacteriaceae (shown in red), which 
adhere to the epithelium, cause barrier damage and invade the intestinal mucosa, is 
caused by loss of Paneth cell-dependent AMP. (4) Damage may be further exacerbated 
by the continued proinflammatory activity of Th1 effectors responding to bacteria and 
parasite antigen. 
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Role of inflammatory monocytes in the intestinal mucosa 
While inflammatory monocytes may be a significant IL-12 source during T. gondii 
infection, their more important function is most likely as chemokine receptor CCR2-
dependent microbicidal effector cells (74). Pioneering studies demonstrated the 
importance of similar cells in defense against Listeria monocytogenes in the spleen 
(75). Subsequently, CCR2-dependent recruitment of these cells into the intestinal 
mucosa of Toxoplasma infected mice was found to control parasite replication (32). 
Rather than controlling migration to the inflamed intestinal LP, CCR2 appears 
necessary for exit from the bone marrow (76). The recruitment of inflammatory 
monocytes into the intestine now appears to be mediated by a CCL3/CCR1 axis (77), a 
finding that confirms older studies showing a requirement for CCR1 in control of 
infection (78). Thus, LP IL-15-dependent NKp46+ innate lymphoid cells activated by 
infection-induced IL-18 produce CCL3 that in turn chemoattracts CCR1-positive 
inflammatory monocytes to the intestinal mucosa (Figure 2.3). 
 
Inflammatory monocytes must be activated by IFN-γ to acquire effector function. In 
an i.p. infection model, NK cells may provide this critical source (79), but our recent 
studies further identified Th1 T cells, recruited to the site of infection in dependence 
upon expression of CXCR3, as an important source of this cytokine in this capacity 
(29). Thus, we can define an intricate chemokine network surrounding Toxoplasma in 
the intestine, in which CCR1/CCL3 recruits CCR2-dependent monocytes, while 
approximately simultaneously, Th1 effector cells are recruited
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through CXCR3 to effect optimal inflammatory monocyte activation for parasite 
control (Figure 2.3). 
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Figure 2.3. Chemokine network surrounding inflammatory monocyte 
recruitment and activation during T. gondii infection. (1) Upon intestinal infection, 
non-hematopoietic cells, such as epithelial cells, are induced to secrete cytokines IL-
18 and IL-15, resulting in activation and maturation of NKp46+ innate-like 
lymphocytes. (2) Concurrently, monocytes are recruited from the bone marrow to the 
bloodstream in dependence upon CCR2. (3) In the intestinal LP, activated, innate-like 
lymphocytes secrete chemokines, such as CCL3. (4) Recruitment of monocytes 
expressing CCR1, a receptor for CCL3, promotes accumulation in the intestinal LP. 
(5) Local production of IFN-γ-inducible chemokines following T. gondii infection 
recruits CXCR3-expressing Th1 cells presumably from the mesenteric lymph node 
(MLN). (6) High level secretion of IFN-γ by CXCR3-positive CD4 T cells activates 
LP inflammatory monocytes, resulting in upregulated antimicrobicidal effector 
function and enabling control of the parasite. 
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It is not yet clear how inflammatory monocytes within the intestine kill parasites. The 
cells were first defined based in part on their ability to express iNOS and produce the 
microbicidal molecule nitric oxide (74, 80). However, because iNOS-deficient mice 
survive acute infection (in contrast to Ifnγ-/- mice) (81, 82), this killing mechanism is 
unlikely. Instead, it is more likely that immunity-related GTPase (IRG) proteins are 
key to parasite killing. IRG effector molecules are strongly induced by IFN-γ, and 
recent data show they accumulate on the parasitophorous vacuole membrane to 
mediate its destruction, thereby depriving the parasite of its essential intracellular 
niche (83-86). Nevertheless, IRG studies have mostly employed in vitro infection 
systems, and while some IRG knockout mice are indeed increased in susceptibility 
during oral infection (87), formal data demonstrating a requirement for this activity in 
mucosal inflammatory monocyte killing is lacking. There is also emerging evidence 
that members of the p65 guanylate-binding protein (GBP) family play a role in 
parasite killing, as deletion of 6 GBP genes resulted in defective recruitment of Irgb6 
to IFN-γ stimulated macrophages in vitro as well as enhanced parasite replication in 
vitro and in vivo, although a role for these proteins during oral infection has yet to be 
confirmed (88). 
 
A more complex view of inflammatory monocytes comes from a recent study 
indicating immunoregulatory properties in the response to Toxoplasma (89). Thus, 
these cells acquire a tissue-specific regulatory phenotype that is dependent upon 
commensals in the gut. This property is associated with production of the lipid 
mediator prostaglandin E2 (PGE2), a molecule known to have immunoregulatory 
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functions in the intestinal mucosa (90). In turn, PGE2 inhibits activation of neutrophils 
that also accumulate in the intestinal LP during T. gondii infection. In the absence of 
CCR2-dependent inflammatory monocyte recruitment, neutrophil activation and 
concomitant release of factors, such as TNF-α and reactive oxygen species, results in 
emergence of intestinal lesions. Thus, inflammatory monocytes recruited to the 
intestine possess the dual properties of controlling parasite growth and down-
modulating PMN-mediated intestinal pathology.      
 
Intraepithelial lymphocyte function during Toxoplasma infection 
Intraepithelial lymphocytes (IEL) constitute a complex population of T cells 
embedded within the intestinal epithelium. They are normally present at 
approximately one per 10 epithelial cells, although this can vary considerably 
depending upon inflammation and infection. In mice, the majority of IEL express 
either CD8αβ or CD8αα and, amongst the latter, a large proportion expresses the gd 
rather than ab T cell receptor (TCR). The origin, antigen specificity, MHC restriction 
and function of these cells are complex and not well understood (91). Nevertheless, 
growing evidence suggests that under normal conditions these cells serve as important 
regulators of homeostasis, and dysregulation in the IEL compartment contributes to 
pathology associated with human IBD (92). 
 
During T. gondii infection, intestinal epithelial tight junction proteins are abnormally 
affected and barrier function is compromised, resulting in decreased control of parasite 
spread (93). Others have shown that CD8αβ IEL isolated from T. gondii-infected mice 
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produce IFN-γ and are capable of cytolytic function against infected enterocytes in 
vitro (94). When adoptively transferred, these IEL traffic to the small intestinal 
mucosa in dependence upon CCR5 and provide protection against challenge infection 
(95-97). Perhaps most interestingly, IFN-γ is required in recipient animals but not 
donor IEL themselves (98).   
 
Populations within the IEL compartment also functionally interact with CD4+ T cells 
in the LP. For example, CD4+ T lymphocytes somehow interact with infected 
epithelial cells to promote proinflammatory cytokine production (99). CD8ab IEL 
down-regulate this activity in dependence upon TGF-β production, suggesting that 
they play a role in protecting against inflammation in the intestine (95, 100). 
Nevertheless, within the IEL population as a whole is embedded the potential to 
contribute to inflammatory pathology during infection (101). During high dose 
infection in C57BL/6 mice, αβTCR CD8α IEL mediate damage that is dependent 
upon their expression of CCR2 (102). The pathogenic IEL population that emerges 
under inflammatory conditions does not function alone, but instead requires LP-
derived CD4 T cells for fulminant pathology (69). In this situation, IEL play a role in 
recruiting CD4+ T lymphocytes into the intraepithelial compartment, providing a 
mechanistic scenario for the original observation that CD4+ T cells are required for 
parasite-mediated ileal damage (103). Taken together, these data indicate that under 
low dose inocula, IEL seem to be important immunoregulatory cells that prevent onset 
of intestinal pathology and may even contribute to control of infection. However, 
under high dose conditions, these cells switch to a dysregulated proinflammatory 
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phenotype that contributes to lesion development in the small intestine. Whether this 
reflects actual switching in the function of a single IEL population or instead results 
from the changing dominance of one IEL population over another is not at present 
understood. Furthermore, while the gut microbiota is required for the pathogenic 
effects of IEL, little is known about how the intestinal flora interact and drive the 
function of these cells.                      
  
Toxoplasma controls the fate of intestinal Treg 
Within the intestinal mucosa resides a large population of FoxP3+ regulatory T cells 
(Treg) composed of steady-state cells (nTreg) and cells induced by infection or 
inflammation (iTreg). These cells are well known to be important in quelling 
inflammation and maintaining tolerance in the intestine, in large part through 
production of anti-inflammatory IL-10 (104). During Toxoplasma infection, IL-10 
clearly has an important role since Il10-/- mice rapidly succumb due to 
proinflammatory cytokine overproduction (105). Within the context of oral infection, 
susceptibility due to IL-10 loss is associated with emergence of Crohn’s like 
pathology in the small intestine (106).     
 
During lethal oral infection, Foxp3+ Treg in the intestine express IL-10 under the 
direction of local IL-27 signaling and have the capacity to suppress T cell responses 
(107), although interestingly they co-express IFN-γ and T-bet. Nevertheless, the 
intestinal Treg population collapses in size with the emergence of inflammatory 
pathology (108). This was shown to be due to expansion of pathogen-specific T cells 
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with limited IL-2 producing capacity, leading to the cytokine starvation of Treg (109). 
Thus, reversal of this collapse was accomplished by the addition of recombinant IL-
2/anti-IL-2 complexes, resulting in fewer effector T cell populations and ameliorated 
pathology. Importantly, the collapse in the Treg population is not restricted to a lethal 
Toxoplasma dose, as a similar loss in Treg occurs under low dose non-lethal parasite 
infection (our unpublished observations and Benson et al.) (109). Indeed, it is 
tempting to speculate that emergence of microbiota-specific T cells associated with 
Toxoplasma infection is enabled by extinguishing tolerogenic Treg in the intestine. 
 
If Treg disappearance in the intestine is a characteristic of Toxoplasma infection, what 
is the source of IL-10 that protects against immune-mediated disease? First, it is 
possible that sufficient numbers of Treg are maintained during nonlethal infection to 
provide protective IL-10. Second, it is possible that other cell types provide IL-10. The 
finding that CD4+ T cell-derived IL-10 is necessary to prevent immunopathology 
during oral T. gondii infection does not distinguish between conventional CD4+ T 
lymphocytes and Treg cells (110). However, in an i.p. infection model it was indeed 
found that IFN-γ-producing Th1 cells switch to IL-10 production as infection 
progresses (111). Other studies have implicated natural killer cells as well as NKT 
cells as significant IL-10 sources during Toxoplasma infection (112, 113). Clearly, 
more work is required to resolve these issues.      
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Conclusions and future directions  
Our knowledge of the mucosal immune responses that are galvanized into action by 
Toxoplasma and other microbial pathogens has expanded greatly in recent years. Yet, 
there is still much that remains unknown. We do not fully understand how cells of the 
mucosal immune system successfully integrate signals received simultaneously from 
microbial pathogens and commensal microbiota during infection, nor do we 
understand the breakdown in tolerance that leads to dysbiosis in the intestine. 
Knowledge gained through use of experimental models such as Toxoplasma will lead 
to new ways of understanding as well as treating infection and inflammation at the 
borders of the intestinal mucosa. 
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Abstract 
Chemokines and their receptors play a critical role in orchestrating immunity to 
microbial pathogens, including the orally acquired Th1-inducing protozoan parasite 
Toxoplasma gondii. Chemokine receptor CXCR3 is associated with Th1 responses, 
and here we use bicistronic CXCR3-eGFP knock-in reporter mice to demonstrate 
upregulation of this chemokine receptor on CD4+ and CD8+ T lymphocytes during 
Toxoplasma infection. We show a critical role for CXCR3 in resistance to the parasite 
in the intestinal mucosa. Absence of the receptor in Cxcr3-/- mice resulted in selective 
loss of ability to control T. gondii specifically in the lamina propria compartment. 
CD4+ T cells were impaired both in their recruitment to the intestinal lamina propria 
and in their ability to secrete IFN-γ upon stimulation. Local recruitment of 
CD11b+Ly6C/G+ inflammatory monocytes, recently reported to be major anti-
Toxoplasma effectors in the intestine, was not impacted by loss of CXCR3. However, 
inflammatory monocyte activation status, as measured by dual production of TNF-α 
and IL-12, was severely impaired in Cxcr3-/- mice. Strikingly, adoptive transfer of 
wild-type but not Ifnγ-/- CD4+ T lymphocytes into Cxcr3-/- animals prior to infection 
corrected the defect in inflammatory macrophage activation, simultaneously reversing 
the susceptibility phenotype of the knockout animals. Our results establish a central 
role for CXCR3 in coordinating innate and adaptive immunity, ensuring generation of 
Th1 effectors and their trafficking to the frontline of infection to program microbial 
killing by inflammatory monocytes.     
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Introduction 
The intestinal mucosa is a critical effector site for elimination of enteric pathogens. 
Toxoplasma gondii, a ubiquitous protozoan parasite, is a prime example of such a 
pathogen. Mammals are infected with T. gondii primarily by the ingestion of tissue 
cysts from undercooked meat or oocysts excreted in the feces of felines, which are the 
sole definitive hosts. Upon infection, the parasite induces a potent Th1 immune 
response that is characterized by high levels of IL-12 and IFN-γ (1, 2). Initial IL-12 
production is largely the result of MyD88-dependent Toll-like receptor (TLR) 
signaling in dendritic cells, and the parasite profilin molecule has been identified as a 
ligand for TLR11 and TLR12 (3-7). IL-12 activates natural killer (NK) cells to initiate 
IFN-γ production and promotes T-cell differentiation towards a Th1 program. 
Ultimately IFN-γ is the critical cytokine involved in controlling Toxoplasma. While in 
vitro experiments suggest that macrophages activated by this cytokine acquire anti-
Toxoplasma activity through upregulation of immunity-related GTPase (IRG) 
molecules that mediate destruction of the parasitophorous vacuole (8-10), the in vivo 
function of IFN-γ is less  clear.  
 
Inflammatory monocytes are an important component of defense against microbial 
pathogens, including Toxoplasma (11). These cells express high levels of Ly6C/G (Gr-
1) and are recruited from the bone marrow via chemokine (C-C motif) receptor 2 
(CCR2) (12). During Listeria monocytogenes infection, inflammatory monocytes are 
recruited from the bone marrow to the spleen and liver where they differentiate into 
TNF-α- and nitric oxide (NO)-producing DCs (Tip-DCs). There they are essential for 
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bacterial clearance and mouse survival (13, 14). Likewise, CCR2-dependent 
inflammatory monocytes are recruited to the lung during Mycobacteria tuberculosis 
infection where they protect mice from disease by recruiting and activating T cells and 
by producing NO (15, 16). Mucosal defense against T. gondii has also recently been 
shown to require CCR2-dependent inflammatory monocytes (11). Upon recruitment to 
the small intestine, these cells control the parasite either indirectly by production of 
IL-12 and TNF-α, or directly through production of NO and IRG proteins (4-6, 8, 9, 
11, 17). While CCR2 enables recruitment of inflammatory monocytes to sites of 
infection, the factors that coordinate their activation and acquisition of effector 
function are not known.    
 
CXCR3 is a Th1-associated chemokine receptor, and cells expressing this receptor 
respond to the IFN-γ-inducible chemokines CXCL9, 10, and 11 (18). The receptor is 
expressed predominantly by T cells and NK cells and is rapidly upregulated upon cell 
activation. There is evidence that CXCR3 expression enables T-cell entry into sites of 
infection, although the outcome of recruitment varies among pathogens. In the case of 
Leishmania major, recruitment is protective as CXCR3-expressing T cells are required 
for the resolution of cutaneous lesions (19). However, in the case of Plasmodium 
berghei ANKA, CXCR3 is pathogenic because it allows entry of proinflammatory 
cells into the CNS, resulting in cerebral malaria (20).  
 
Here we determined the role of CXCR3 in the intestinal immune response to 
Toxoplasma. We found that loss of CXCR3 negatively affected host survival against 
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oral infection. This was associated with diminished recruitment of CD4+ T cells to the 
lamina propria (LP), decreased T cell IFN-γ secretion,  impaired inflammatory 
monocyte effector function, and inability to control the parasite in the intestinal 
mucosa. Reconstitution with CXCR3-competent CD4+ T cells restored inflammatory 
monocyte function, resulting in improved survival against the parasite. Protective 
effects of adoptively transferred CD4+ T lymphocytes depended upon their ability to 
produce IFN-γ, but occurred independently of CD4 expression of CD40L. Our data 
show that CXCR3 enables Th1 recruitment to the intestinal LP, where these cells 
instruct activation of CCR2-dependent inflammatory monocytes, in turn controlling 
infection. These results establish CXCR3 as a major determinant orchestrating 
communication between effectors of innate and adaptive immunity, enabling effective 
host defense against infection.  
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Results 
CXCR3 and its ligands CXCL9 and CXCL10 are upregulated during acute 
toxoplasmosis  
Because CXCR3 and its chemokine ligands are strongly associated with Th1 
responses, we asked whether this proinflammatory axis was induced during 
Toxoplasma infection in the intestinal mucosa. Accordingly, mice were orally 
inoculated with cysts, and relative levels of CXCR3, CXCL9 and CXCL10 mRNA 
expression were measured over the course of acute infection. We found strong 
upregulation of CXCR3 and its specific chemokine ligands as early as Day 4 post-
infection in both the ileum and mesenteric lymph nodes (MLN) (Figure 3.1A). 
Overall, peak CXCR3 mRNA levels were attained by Day 6 post-inoculation.    
 
In order to examine CXCR3 expression in more detail, we utilized Cxcr3 eGFP 
reporter (CIBER) mice, a bicistronic reporter strain in which cells expressing CXCR3 
also express eGFP (21). We found a large increase in CXCR3 populations of both 
CD4+ and CD8+ T lymphocytes in MLN, spleen (SPL) and LP compartments 
following infection (Figure 3.1B). In general, CXCR3 upregulation was most 
pronounced in the CD4+ population. For example, in the MLN there was a 6-fold 
increase in CD4+CXCR3+ cells but only a 2-fold increase in CD8+CXCR3+ 
lymphocytes. NK cells are also known to express CXCR3 and are an important source 
of early IFN-γ during T. gondii infection (22, 23). However, while CXCR3-GFP 
expression was relatively high on naïve NK cells, the GFP expression was in fact 
reduced during infection, suggesting lack of a role for CXCR3+ NK cells during 
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intestinal infection (Figure 3.2). We next examined expression of the activation 
marker CD27 on GFP+ and GFP- T lymphocytes in infected mice. CD27 was 
significantly lower in CXCR3-GFP- cells, suggesting an altered maturation state of the 
CXCR3- T cells (Figure 3.3A and B). Likewise, there was a lower percentage of 
CD27+ cells amongst CXCR3-GFP- CD8+ T lymphocytes, although the decreases in 
expression were not as striking as with the CD4+ lymphocytes (Figure 3.3C and D). 
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Figure 3.1. CXCR3 and its ligands are upregulated following T. gondii infection.  
(A) CXCR3, CXCL9, and CXCL10 gene expression was assessed by semi-
quantitative real time PCR in mesenteric lymph nodes (MLN) and small intestinal 
tissue from WT mice during oral T. gondii infection. The results are expressed as fold 
change relative to tissues from noninfected animals (n=4 mice per time point). (B) 
CXCR3 protein expression was quantified using flow cytometry by measuring GFP 
levels before (noninfected, NI) and 11 days after oral infection (INF) of CIBER mice. 
GFP levels were assessed among CD4+ and CD8+ T-cell subsets from MLN, spleen 
(SPL), and small intestinal lamina propria. NI, noninfected; INF, infected.  
 71 
 
Figure 3.2 CXCR3-GFP expression on NK cells decreases during infection. 
Lamina propria and mesenteric lymph node (MLN) leukocytes were isolated from 
noninfected (NI) and Day 7-infected (INF) CIBER reporter mice, and CXCR3-GFP 
expression was measured on NK1.1+ cells. Numbers in each panel indicate the percent 
of NK1.1+ cells falling within the CXCR3-eGFP positive quadrant. 
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Figure 3.3. CXCR3-GFP+ and CXCR3-GFP- fractions of CD4+ T cells 
differentially express activation markers. Splenocytes (n=4), MLN (n=5), and 
Peyer’s patch (n=2) cells were isolated from Day 11-infected CIBER reporter mice 
and stained for surface markers CD27 as well as CD4 (A and B) and CD8 (C and D). 
Representative mice are shown in A and C. Bar graphs (B and D) represent averages 
of multiple mice, and significance is represented by * p<0.05, and *** p<0.001. 
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Cxcr3-/- mice are increased in susceptibility and are prone to severe intestinal 
damage following T. gondii infection 
To further examine the role of CXCR3 during T. gondii infection, mice deficient in 
CXCR3 were orally inoculated with low virulence ME49 cysts, and the outcome of 
infection was monitored. While all wild-type (WT) mice survived acute infection with 
30 cysts, Cxcr3-/- animals displayed increased susceptibility with nearly 75% of mice 
dying by 2 weeks post-infection (Figure 3.4A). When the cyst dose was increased to 
50, all CXCR3 knockout (KO) mice rapidly succumbed to infection, but some WT 
mice also died (Figire 3.4B). Interestingly, when WT and KO mice were infected by 
intraperitoneal injection, lack of CXCR3 did not affect survival, indicating that the 
effect of CXCR3 is specific to the mucosal response (Figure 3.5A). To further 
examine the overall response in orally infected mice, we examined the gross 
appearance of the small intestine of WT and Cxcr3-/- mice after 30-cyst infection. The 
small intestines of the KO mice were strikingly damaged as demonstrated by massive 
hemorrhage compared to WT (Figure 3.4C). Consistent with intestinal shortening 
associated with increased damage (24-26), the length of the small intestine was 
reduced in the KO mice during infection (Figure 3.4D). Increased damage was further 
confirmed by H&E staining of small intestinal sections. WT mice displayed minor 
villus blunting accompanied by moderate to severe inflammatory cell recruitment in 
the submucosa (Figure 3.4E and G). In contrast, Cxcr3-/- mice displayed severe villus 
blunting, fusion, epithelial necrosis, sloughing of villus tips, and vascular congestion 
and hemorrhage (Figure 3.4F and H). Blind scoring of H&E sections revealed a 
significant decrease in inflammation scores in the absence of CXCR3 (Figure 3.4I), 
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but when parameters of intestinal damage were quantitated, Cxcr3-/- mice scored 
significantly higher than WT counterparts (Figure 3.4J). This damage was infection-
dependent as intestines from non-infected WT and Cxcr3-/- mice both had normal 
architecture with few inflammatory cells (Figure 3.5B). Increased epithelial damage in 
the absence of CXCR3 was further verified by loss of epithelial surface-associated 
Muc1 compared to infected WT animals, suggesting epithelial cell sloughing (Figure 
3.5C). Despite the overall decreased inflammatory score, Cxcr3-/- mice consistently 
displayed an influx of neutrophils into the LP compartment compared to WT mice, 
suggesting a role for these cells in causing damage, as argued by others (13, 14, 27) 
(Figure 3.5D and E). 
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Figure 3.4. Cxcr3-/- mice are susceptible to severe intestinal pathology following 
oral T. gondii infection. WT and CXCR3-deficient mice were orally inoculated with 
30 ME49 cysts (p<0.01) (A) or 50 cysts (p<0.0001) (B) of T. gondii and monitored for 
survival. In another set of experiments (C-J), mice were orally inoculated with 30 
ME49 cysts, and tissues were collected at Day 10 post-infection. (C) Gross intestinal 
lesions in representative WT and CXCR3 KO mice. (D) Average lengths of 
noninfected (NI) and infected (INF) WT and Cxcr3-/- small intestines (NI WT, n=5; NI 
KO, n=3; INF WT, n=8, INF KO: n=7). E-H, H&E stained sections of small intestines 
from infected WT (E and G) and KO (F and H) mice. In panel G, the arrow points to 
an area of inflammatory cell influx. In panel H, the yellow arrow indicates an area of 
vascular congestion, and the red arrow indicates a necrotic villus. Blind scoring was 
performed on H&E stained intestine sections for inflammation (I) and damage (J) 
criteria (WT: n=14; KO: n=13; * p<0.05, ** p<0.01, *** p<0.001). Pooled data are 
represented as mean +/- SEM.  
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Figure 3.5. Cxcr3-/- mice are more susceptible to oral infection with Toxoplasma. 
(A) WT and KO mice (n=5 per group) were infected by i.p. injection of 30 ME49 
cysts, and survival was monitored (p=0.371). (B) Small intestines of naïve WT and 
KO mice (n=3 per strain) were harvested, fixed in formaldehyde, embedded in 
paraffin, and sections were stained with H&E. (C) Frozen sections of Day 10 WT and 
Cxcr3-/- intestines were stained for Muc1 followed by anti-rabbit Alexa-488 (red). 
Sections were counter-stained with DAPI (blue). (D) Lamina propria leukocytes from 
Day 9-orally infected WT and Cxcr3-/- mice were stained for neutrophil markers 
Ly6C/G (Gr-1) and Ly6G (1A8). (E) Neutrophil levels were assessed in individual 
mice (n=5 per group). The graph shows mean +/- SEM (** p<0.01). 
 79 
Cxcr3-/- mice are unable to control parasite replication in the small intestine 
Genetic knockout of cytokines such as IFN-γ results in susceptibility to T. gondii 
through the inability to control parasite replication, whereas the deletion of anti-
inflammatory mediators such as IL-10 results in susceptibility due to cytokine 
pathology (28, 29). Based on decreased inflammation scores, we hypothesized that the 
Cxcr3-/- mice were more likely to be succumbing from uncontrolled parasite 
replication rather than immune-mediated damage. To examine this, intestinal tissues 
were stained for parasite antigen by immunohistochemistry. Sections from WT mice 
displayed minimal parasite infiltration within the LP (Figure 3.6A). Conversely, 
Cxcr3-/- mice contained numerous large foci of parasite throughout the length of the 
small intestine that often coincided with areas of severe damage (Figure 3.6B). 
Surprisingly, this difference was restricted to the LP and submucosa of the small 
intestine because Peyer’s patches (PP) in WT and Cxcr3-/- mice contained similar 
levels of parasite antigen (Figure 3.6C and D). Differences in parasite burden between 
WT and Cxcr3-/- mice in the MLN, spleen, and lung were also indiscernible by IHC 
analysis (data not shown). These results were further confirmed by quantitative PCR. 
Thus, while lung, liver, spleen, MLN and PP contained similar levels of parasite 
genomes regardless of CXCR3 expression, there was an approximately 50-fold 
increase in parasite levels in the absence of CXCR3 in intestinal tissues (Figure 3.6E). 
These data suggest that increased susceptibility to Toxoplasma in Cxcr3-/- mice was 
due to a localized inability to control parasite replication within the LP of the small 
intestine.  
 80 
 
 
Figure 3.6. Intestinal parasite burden is elevated in Cxcr3-/- mice. Paraffin sections 
of Day 10-infected WT and Cxcr3-/- small intestines were stained by 
immunohistochemistry for T. gondii antigen. Shown are representative images of WT 
LP (A), Cxcr3-/- LP (B), WT Peyer’s patch (C), and Cxcr3-/- Peyer’s patch (D) with 
positive parasite staining in brown. (E) Lung (WT: n=3; KO: n=4), liver (WT: n=5; 
KO: n=4), spleen (WT: n=5; KO: n=4), MLN (WT: n=3; KO: n=5), Peyer’s patches 
(PP, WT: n=2, KO: n=2) and small intestines (WT: n=5; KO: n=4) were harvested 
during acute infection, and DNA was isolated from tissues and subjected to 
quantitative PCR amplification for the parasite B1 gene and the host arginosuccinate 
lyase gene. Parasite burden was quantitated as parasite to host genome equivalents and 
was calculated by comparison to a standard curve obtained from known amounts of 
Toxoplasma. Pooled ratios are represented as mean +/- SEM where **p<0.01. 
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CD4+ T cells are recruited to the small intestine via CXCR3  
The dominant effector cells required for elimination of T. gondii following oral 
infection are inflammatory monocytes. These cells express Ly6C/G (Gr-1), produce 
TNF-α, IL-12, and are likely to kill parasites via activation of IFN-γ-inducible p47 
GTPases that assemble at the parasitophorous vacuole membrane and mediate its 
destruction (8, 11). Consistent with others (11), we observed these cells in the LP of 
infected mice (Figure 3.7A). Inflammatory monocytes are dependent upon CCR2 for 
exit from the bone marrow, but we wondered whether CXCR3 might be involved in 
recruiting these cells to the LP in response to T. gondii. Therefore, we examined 
CXCR3-GFP expression by intestinal inflammatory monocytes during infection. 
Inflammatory monocytes in the small intestinal LP of infected reporter mice did not 
express any GFP as compared to inflammatory monocytes isolated from infected 
Cxcr3-/- mice (Figure 3.7B). In stark contrast, approximately 50% of LP CD4+ T cells 
expressed high levels of GFP (Figure 3.7C). Furthermore, Cxcr3-/- mice displayed 
unaltered total numbers of LP inflammatory monocytes compared to wild-type 
controls (defined as CD11b+Ly6C+Ly6G-) (Figure 3.7D). We next assessed the 
kinetics by which CD4+ T cells and inflammatory monocytes were recruited to the 
lamina propria during infection. Between days 4 and 7 of infection, there was a 
significant increase in the total numbers of CD4+CXCR3-GFP+ T cells and 
inflammatory monocytes (Figure 3.7E). However, the total number of CD4+CXCR3-
GFP- cells remained unchanged, further indicating that infection promotes the 
recruitment of CD4+CXCR3+ T cells (Figure 3.7E). Few NK cells were observed in 
the lamina propria, but there was a small increase in their number during infection. 
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This was attributable to an increase in CXCR3- NK cells (data not shown). Consistent 
with these results, there was an influx of CD4+ T cells in WT small intestines that was 
diminished in Cxcr3-/- mice (Figure 3.7F-H). These findings demonstrate that CD4+ T 
cells fail to effectively traffic to the intestinal compartment in the absence of CXCR3, 
but the presence of LP inflammatory monocytes does not require this chemokine 
receptor. 
 
Lamina propria CD4+ T cells display impaired IFN-γ  production 
We next asked if expression of CXCR3 affected the ability of T cells to secrete the 
Th1 cytokine IFN-γ. Initial experiments on bulk populations of splenocytes and 
mesenteric lymph node (MLN) cells from Day-11 infected WT and KO revealed no 
differences in the amount of IFN-γ, TNF-α or IL-10 produced during in vitro culture 
(Figure 3.8). To specifically examine functional outcomes in intestinal cells, WT and 
Cxcr3-/- lamina propria leukocytes were harvested 4 and 6 days post-oral infection, 
stimulated ex vivo, and IFN-γ production was examined by flow cytometry. CD4+ T 
cells from both WT and Cxcr3-/- displayed enhanced IFN-γ production over time. 
However, in the absence of CXCR3, CD4+ T cells produced significantly less IFN-γ 
compared to WT cells at both examined time points (Figure 3.9A-E). This was 
confirmed by measuring IFN-γ from the supernatants of Day-6 WT and Cxcr3-/- 
intestinal biopsy cultures, where IFN-γ was lower in the absence of CXCR3 (Figure 
3.9F). This effect was specific to the CD4+ T cell subset, as IFN-γ production by 
lamina propria CD8+ T cells and NK cells was unchanged between WT and knockout 
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animals (Figure 3.10A-F). Further confirming that this loss of IFN-γ production was 
specific to CD4+ T lymphocytes in the small intestine, and consistent with the bulk 
splenocyte culture experiments, splenocytes isolated from infected WT and Cxcr3-/- 
mice secreted equivalent levels of IFN-γ upon ex vivo stimulation with PMA and 
ionomycin (Figure 3.10G-I). Together, these results indicate an intestine-specific 
defect in presence of CD4+ Th1 cells in the absence of CXCR3 as measured by the 
capacity to produce IFN-γ. 
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Figure 3.7. CD4+ T-cell recruitment, but not the presence of inflammatory 
monocytes, is impaired in the small intestine in the absence of CXCR3. (A) Frozen 
sections of intestines from infected WT mice were co-stained for Ly6C/G (Gr-1) 
(green) and iNOS (red) to confirm the presence of inflammatory monocytes in the 
mucosa of Day 6-infected animals. (B and C) Small intestinal LP cells were isolated 
from CXCR3-GFP reporters and Cxcr3-/- mice 6 days following oral infection. In the 
CXCR3 reporter mice, inflammatory monocytes (B, blue line) and CD4+ T cells (C, 
red line) were assessed for GFP expression by flow cytometry as compared to Cxcr3-/- 
cells (gray shaded in both histograms). (D) Total numbers of lamina propria 
inflammatory monocytes 6 days after infection. Neutrophils were excluded by gating 
on Ly6G-negative cells. (E) Total numbers of CD4+CXCR3-GFP+ T cells, 
CD4+CXCR3-GFP- T cells, inflammatory monocytes, and NK cells in the lamina 
propria of WT and Cxcr3-/- mice 4 and 7 days post-infection. Statistical comparisons 
were made between time points of respective cell types, where * p <0.05 and ** p 
<0.01. In panels F-G, WT (F) and Cxcr3-/- (G) intestinal frozen sections were stained 
with anti-CD4 antibody followed by anti-rat Alexa-647. Sections were visualized by 
immunofluorescence microscopy. (H) To quantify CD4+ T-cell infiltration, the ratio of 
Alexa-647 over DAPI fluorescence was calculated (WT: n=3; KO: n=3; 6-12 
fields/mouse; p<0.01). Pooled ratios are represented as mean +/- SEM. 
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Figure 3.8. Cytokine responses in WT and KO mice. Splenocytes (A, C and E) and 
MLN (B, D and F) were harvested from Day 11-infected WT and Cxcr3-/- mice and 
cultured in the presence of soluble tachyzoite antigen (STAg) for 72 hr. Supernatants 
were collected, and IFN-γ (A and B), TNF-α (C and D), and IL-10 (E and F) were 
measured by ELISA.  
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Figure 3.9. Lamina propria CD4+ T cells display impaired IFN-γ  production. 
Lamina propria leukocytes were harvested from WT and Cxcr3-/- mice at Day 4 (A-B) 
and Day 6 (C-D) post-infection, cultured in the presence of PMA, ionomycin, and 
Brefeldin-A for 6 hrs, and assessed for IFN-γ production by flow cytometry. The 
means and standard errors of individual mice are shown in E (Day 4, n=10 per strain; 
Day 6 n=6 per strain). Intestinal biopsy cultures were performed at Day-6 post-
infection, and IFN-γ was measured in the supernatants after 24 hr of culture (F). Each 
dot represents an individual mouse, and *p<0.05. 
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Figure 3.10. T cell and NK cell production of IFN-γ  in the presence and absence 
of CXCR3. Lamina propria leukocytes were isolated from WT (A) and Cxcr3-/- (B) 
mice 6 days post-infection, cultured for 6 hr in the presence of PMA, ionomycin, and 
Brefeldin-A, and stained for CD8 and IFN-γ. (C) Means and standard errors of 
individual mice. Lamina propria leukocytes were isolated from WT (D) and Cxcr3-/- 
(E) mice, cultured in the presence of PMA, ionomycin, and Brefeldin-A and stained 
for NK1.1 and IFN-γ. (F) Mean and standard error of individual mice (WT: n=9; KO: 
n=6). Splenocytes were harvested from WT (G) and Cxcr3-/- (H) Day 7-infected mice, 
cultured in the presence of PMA, ionomycin, and Brefeldin-A, and stained for CD4 
and IFN-γ. (I) Mean and standard error of individual mice (WT: n=2; KO: n=2). 
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Inflammatory monocyte responses in the intestinal mucosa are defective in the 
absence of CXCR3  
Although IFN-γ, IL-10, and TNF-α responses remained intact in the MLN and spleen 
late during infection of CXCR3-deficient mice, a significant decrease in IL-12 
production was observed in the MLN (Figure 3.11A) and spleen (Figure 11B) of 
Cxcr3-/- mice. Defective IL-12 responses in the CXCR3 KO strain were infection 
dependent, because parasite antigen stimulated equivalent amounts of IL-12 in 
noninfected WT and KO splenocytes (Figure 3.11C). This response, known to derive 
from resident splenic CD8α+ DC (30), may account for equivalent Th1 priming in 
secondary lymphoid organs, despite lower IL-12 levels during late acute infection. 
 
Since IL-12 is also a characteristic cytokine of inflammatory monocytes, we 
investigated the impact of CXCR3 deletion on intestinal inflammatory monocyte 
function. Indeed, in vitro culture of intestinal biopsy samples revealed decreased 
production of IL-12 (Figure 3.11D). To further identify the source of the defective IL-
12, we examined the production of IL-12 from inflammatory monocytes. While the 
total numbers of LP inflammatory monocytes were equivalent in WT and CXCR3 KO 
mice (Figure 3.7B), the population of CD11b+Gr-1+ cells co-expressing IL-12 and 
TNF-α was dependent upon CXCR3 (Figure 3.11E and F). Further confirming 
impaired inflammatory monocyte function, iNOS expression was significantly 
decreased in inflammatory monocytes (Figure 3.11G and H). These findings strongly 
suggest that inflammatory monocytes are functionally impaired in the absence of 
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CXCR3. Interestingly, neutrophils in the LP of KO mice produced significantly higher 
levels of TNF-α compared to WT neutrophils (Figure 3.12A and B). 
 91 
 
 
 92 
 
 
Figure 3.11. Inflammatory monocyte function is impaired in the absence of 
CXCR3. MLN cells (A) and splenocytes (B) from Day 11-infected WT and Cxcr3-/- 
mice were cultured for 72 hours in complete DMEM in the presence of soluble 
tachyzoite antigen (STAg) (n=5 mice per strain). Supernatants were then collected and 
assayed for IL-12p40 by ELISA. (C) Naïve splenocytes were cultured with soluble 
tachyzoite lysate for 48h, and culture supernatants were assayed for IL-12p40 
secretion. (D) Intestinal biopsy samples from noninfected (NI) and Day 9-infected 
(INF) WT and Cxcr3-/- mice were cultured overnight, then supernatants were collected 
and assayed for IL-12p40. (WT: n=18; KO: n=16). Data are represented as mean +/- 
SEM. (E) Lamina propria leukocytes from Day 9-infected WT and Cxcr3-/- mice were 
cultured in the presence of Brefeldin-A for 6 hr. Cells were surface stained for CD11b, 
Ly6G (1A8), and Ly6C/G (Gr-1) then intracellularly stained for IL-12 and TNF-α. 
The cell populations shown are gated on CD11b+Gr-1+1A8- cells, and the quadrants 
represent proportions of cells positive for each cytokine. (F) IL-12+TNF-α+ 
inflammatory monocyte levels in the lamina propria of individual mice. Each dot 
represents results from a single mouse. (G) Leukocytes were isolated from the MLN 
of Day 4-infected WT and Cxcr3-/- animals and stained for iNOS by flow cytometry. 
(H) The means of multiple mice are plotted (WT: n=10; KO: n=9). In this figure, * 
p<0.05, ** p<0.01, *** p<0.001. 
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Figure 3.12. Lamina propria neutrophils secrete elevated TNF-α  in the absence 
of CXCR3. Lamina propria leukocytes were harvested from WT and Cxcr3-/- mice 
and cultured in the presence of Brefeldin-A for 6 hr. Cells were then stained for 
neutrophil markers CD11b, Ly6C/G (Gr-1), and Ly6G (1A8), fixed, permeabilized, 
and intracellularly stained for TNF-α. Cytokine production was assessed by flow 
cytometry (A). Shown are the mean +/- SEM of individual mice (B) (n=5 per group, 
** p<0.01). 
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Adoptive transfer of WT CD4+ T lymphocytes rescues inflammatory monocyte 
function and restores resistance in Cxcr3-/- mice  
Given the data so far, we hypothesized that CD4+ T cells were unable to effectively 
home to the small intestine and prime inflammatory monocyte function in the absence 
of CXCR3, resulting in susceptibility to Toxoplasma. We therefore tested whether 
reconstitution with CXCR3-competent CD4+ T cells would allow Cxcr3-/- mice to 
overcome susceptibility and restore inflammatory monocyte function. Accordingly, 
CD4+ T cells from naïve WT spleens were enriched to 90-95% purity by magnetic 
bead separation (Figure 3.13A) and injected i.v. into Cxcr3-/- recipients. Mice were 
orally challenged with T. gondii 24 hours post-adoptive transfer, and survival was 
monitored. Knockout mice that did not receive WT cells began to die 10 days post-
challenge, while all KO mice that received CD4+ T cells and all WT controls survived 
the acute phase of infection (Figure 3.13B). To confirm that the CD4-dependent 
survival was not an artifact of the transfer, Cxcr3-/- CD4+ T cells were adoptively 
transferred into KO recipients. The knockout cells were unable to protect against 
susceptibility, demonstrating that protection is dependent on CXCR3 expression by 
CD4+ T cells (Figure 3.14A).  
 
To assess the functional impact of WT CD4 adoptive transfer, parasite burden and 
cytokine production in the LP were assessed by flow cytometry in WT, Cxcr3-/-, and 
Cxcr3-/- + CD4 mice. While Cxcr3-/- mice had a clear increase in Toxoplasma infected 
cells relative to WT, upon adoptive transfer of WT CD4+ T cells, parasite levels were 
reduced to WT (Figure 3.13C). Likewise, expression of IL-12/TNF-α by 
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inflammatory monocytes was significantly reduced in KO mice, but these cytokines 
returned to WT levels upon transfer of WT CD4+ T cells (Figure 3.13D and Figure 
3.14B). In addition to cytokine responses, intestinal damage was also alleviated by 
adoptive transfer of WT CD4+ T cells, as the intestinal lengths of the transferred mice 
were restored to WT (Figure 3.13E). Possibly as a result of improved monocyte 
function and parasite clearance, neutrophil levels and neutrophil TNF-α secretion 
were also restored to WT levels following the transfer of WT CD4+ T cells (Figure 
3.14C and D).  
 
CD4+ T-cell rescue is dependent on IFN-γ  but independent of CD40L 
To identify the mechanism behind the rescue of Cxcr3-/- susceptibility by WT CD4+ T 
cells, we performed adoptive transfer experiments utilizing T cells derived from 
knockout animals. Inasmuch as CXCR3 is a Th1 chemokine receptor, we began by 
asking whether reversal of susceptibility was dependent on CD4-derived IFN-
γ. Therefore, CD4+ T cells were isolated from IFN-γ-/- mice and adoptively transferred 
into CXCR3-deficient recipients. Unlike IFN-γ-competent CD4+ T cells (Figure 3.13B 
and Figure 3.15B), transfer of IFN-γ KO CD4+ T lymphocytes failed to provide 
significant protection (Figure 3.15A). It has been shown that CD40L contributes to 
inflammatory responses in the intestinal mucosa during oral Toxoplasma infection 
(31). Therefore, we performed the adoptive transfer using CD40L-/- CD4+ T cells and 
assessed survival. As expected, CXCR3-deficient animals were highly susceptible to 
infection. However, Cxcr3-/- mice receiving CD40L-/- CD4+ T cells survived the 
infection, indicating that CD40L does not mediate CXCR3+CD4+-dependent 
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protection (Figure 3.15B). 
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Figure 3.13. Adoptive transfer of WT CD4+ T cells into Cxcr3-/- mice confers 
resistance to infection. (A) Splenocytes from naïve WT mice were sorted for CD4+ T 
cells by magnetic bead separation. Pre-sort and post-sort fractions were stained for 
CD4 and CD8 to confirm efficacy of the sort. (B) Purified CD4+ T cells (5x106) from 
noninfected mice were adoptively transferred by intravenous injection into Cxcr3-/- 
recipients (n=5 mice per group). Mice were orally challenged 24 hr post-transfer with 
T. gondii (30 cysts), and survival was monitored. ***, p<0.001 comparing Cxcr3-/- 
with Cxcr3-/- + CD4+ T cells. (C-E) Lamina propria leukocytes were isolated from 
WT, Cxcr3-/- controls, and Cxcr3-/- CD4+ T-cell recipients at Day 9 post-infection (n=5 
mice per group). (C) Total cells were stained for Toxoplasma surface antigen (SAG)-1 
to determine parasite infection. (D) Cells were also cultured in the presence of 
Brefeldin-A for 6 hours, after which they were surface stained for CD11b, Gr-1, and 
Ly6G and stained intracellularly for IL-12 and TNF-α. (E) Small intestinal length was 
compared between WT, Cxcr3-/-, and Cxcr3-/- adoptive transfer recipient mice (WT: 
n=11; KO: n=10; Transfer: n=3). Data are represented as mean +/- SEM, where * 
p<0.05 and ** p<0.01 
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Figure 3.14. Adoptive transfer of CXCR3+CD4+ T cells into Cxcr3-/- recipients 
protects against oral Toxoplasma infection. (A) Splenic CD4+ T cells were isolated 
from naive Cxcr3-/- mice, and 5x106 cells were adoptively transferred intravenously 
into Cxcr3-/- recipients. Mice were orally challenged 24 hr later with 30 ME49 cysts 
and assessed for survival (n=5 mice per group). (B) Lamina propria leukocytes were 
harvested from infected WT and Cxcr3-/- mice and cultured in the presence of 
Brefeldin-A for 6 hr. Cells were surface stained for CD11b, Ly6C/G (Gr-1), and Ly6G 
to identify inflammatory monocytes. Cells were then fixed, permeabilized, and 
intracellularly stained for IL-12 and TNF-α. Cytokine production by inflammatory 
monocytes was analyzed by flow cytometry. Shown are representative FACS plots of 
individual mice. (C) Lamina propria leukocytes were surface stained for CD11b, 
Ly6C/G (Gr-1), and Ly6G (1A8) to identify neutrophils. (D) Cells were then fixed, 
permeabilized, and intracellulary stained for TNF-α. Cytokine production by 
neutrophils was analyzed by flow cytometry. Shown are the mean +/- SEM of 
individual mice (n=5 mice per group; * p<0.05, ** p<0.01).
 101
 
 
 
Figure 3.15. CD4-mediated rescue is dependent on IFN-γ  but independent of 
CD40L. CD4+ T cells were isolated from Ifn-γ-/- (A) and CD40L-/- (B) mice, 
adoptively transferred into Cxcr3-/- mice that were subsequently challenged with 
Toxoplasma as described in the Figure 6 legend (WT: n=10; KO: n=11; Ifn-γ-/-: n=11; 
CD40L-/-: n=5).   
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Discussion 
Effective control of pathogens such as T. gondii requires the coordinated action of 
cells of innate and adaptive immunity. Orchestration of the response is governed by an 
underlying network of chemokines and chemokine receptor-expressing cells in both 
the hematopoietic and non-hematopoietic compartments. In this study, we demonstrate 
a central role for chemokine receptor CXCR3 in empowering Th1 trafficking to the 
small intestine, in turn enabling inflammatory monocyte activation and concomitant 
control of infection. While the importance of IFN-γ-secreting CD4+ T cells in 
resistance to Toxoplasma is well known to researchers in the field (28, 32, 33), and 
while the importance of anti-microbial inflammatory monocytes has recently become 
clear in the context of Toxoplasma and other infections (11), the present study is the 
first to reveal the functional link between CXCR3+ T-cell effectors, IFN-γ and 
inflammatory monocyte activation in tissues of the intestinal mucosa.  
 
Although Th1 effectors depend upon CXCR3 to reach the site of infection, 
inflammatory monocytes require chemokine receptor CCR2 for optimal trafficking. In 
the latter case, inflammatory monocytes fail to exit the bone marrow in Ccr2-/- mice, 
resulting in a decreased level of this population in the periphery, in turn resulting in 
inability to control T. gondii infection (11). Monocytes have also been suggested to 
promote the systemic dissemination of T. gondii to the brain (34). While brain parasite 
loads were not examined in this study, it is unlikely that altered parasite shuttling is a 
mechanism by which the knockout animals are succumbing to Toxoplasma because 
peripheral parasite loads were not affected by absence of CXCR3 (Figure 3.6B). Our 
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data argue that the basis for increased parasites specifically in the intestine is the result 
of defective regional control by inflammatory monocytes that lack CXCR3-dependent 
activation signals. Recent data indicate that inflammatory monocyte expression of 
CCR1 enables a response to IL-15-dependent CCL3-secreting innate lymphoid cells, 
resulting in CCR1-dependent recruitment to the intestinal mucosa of Toxoplasma 
infected mice (35). Taking these data and ours collectively, we propose that CXCR3, 
CCR2 and CCR1 act together as a control axis of innate and acquired immunity in 
intestinal immunity, ensuring coordinated recruitment of inflammatory monocytes and 
Th1 effectors to inflamed tissues.   
 
It was recently demonstrated that NK cell-derived IFN-γ controls the differentiation of 
circulating monocytes into inflammatory dendritic cells during i. p. T. gondii infection, 
and is thus required for an optimal IL-12 response (36). In our model we did not see a 
dependence on CXCR3 for NK cell recruitment, as NK cells appeared to lose CXCR3-
GFP expression over the course of infection (Figure 2.2), and production of NK cell 
IFN-γ was equivalent in WT and KO mice (Figure 3.10D-F). This difference may be 
attributable to the alternative routes of infection used, as our model incorporates the 
intestinal response, while the i.p. route bypasses the intestinal mucosa. Consistent with 
this idea, absence of CXCR3 did not affect the ability of mice to survive i. p. infection 
(Figure 3.5A).  
 
While our study focuses on the early response to Toxoplasma infection in the intestinal 
mucosa, others have examined the role of CXCR3 and its ligands in additional tissues 
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and at different stages of infection. Antibody-mediated depletion of CXCL10, a major 
CXCR3 ligand, increases susceptibility and blocks influx and expansion of T cells in 
the liver and spleen that accompanies T. gondii infection (37). Additionally, a study of 
ocular toxoplasmosis revealed that T cells infiltrating the eye during infection express 
CXCR3 and produce IFN-γ. Depletion of CXCL10 in this model reduced the number 
of infiltrating T lymphocytes during chronic infection, resulting in increased parasite 
replication and ocular damage (38). Recently, CXCL10 was shown to impact CD8+ T-
cell mobility in the brain of chronically infected mice, enhancing their ability to 
control the parasite by increasing contact with infected cells (39). Our results for the 
first time highlight the importance of CXCR3 and its impact on CCR2-dependent 
monocytes in the initial protective response to the parasite in the intestine.   
 
It has been shown that TGF-b production by intestinal IEL protects against T. gondii-
induced damage by down-modulating inflammation (40). While we did not examine 
intraepithelial lymphocytes (IEL) in this study, it is possible that CXCR3 expression 
could also affect trafficking and function of this cell type, thereby contributing to 
resistance in this model. Future studies will examine whether CXCR3-expressing IEL 
play a role in immunity to oral T. gondii infection. 
 
CXCR3 has also been assessed for its role in immunity to other protozoan pathogens, 
including Leishmania and Plasmodium. Interestingly, the function of CXCR3 differs 
depending upon the parasite, the route of infection and the site examined. For 
example, Cxcr3-/- mice exhibit impaired IFN-γ production and increased lesion 
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development during cutaneous L. major infection, but the knockout mice are not more 
susceptible to hepatic L. donovani infection (19, 41). Furthermore, CXCR3 and its 
chemokines promote cerebral inflammation and mortality during experimental malaria 
infection (20, 42). Overall, CXCR3 and its chemokine ligands function as double-
edged swords, inasmuch as they make an important contribution to protective 
immunity, but when dysregulated they are the cause of deleterious immunopathology.  
 
In addition to its role in cell recruitment, CXCR3 has recently been suggested to be 
important for priming CD4+ T cells in the lymph node to become Th1 cells by 
promoting long-lasting interactions between T cells and CXCL10-expressing dendritic 
cells. In the absence of CXCR3, T cells fail to fully differentiate into IFN-γ-producing 
cells and are defective during subsequent lymphocytic choriomeningitis virus (LCMV) 
infection (43). We found no evidence for defective Th1 responses in secondary 
lymphoid organs during Toxoplasma infection of Cxcr3-/- mice, a result that is 
supported by similar findings during L. major infection (19). However, our results are 
consistent with impaired recruitment of Th1 cells in the absence of CXCR3, as lamina 
propria CD4+ T cells from Cxcr3-/- mice exhibited defective IFN-γ production. We 
conclude that the function of CXCR3 in promoting Th1 differentiation versus, or in 
addition to, homing to inflammatory sites is likely to be a context-dependent 
phenomenon.  
 
Although we found no differences in T-cell activation in CXCR3 negative T cells of 
reporter mice or in CXCR3 KO animals, as measured by expression of CD25, CD69 
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and CD44 (data not shown), we observed a consistent decrease in CD27 expression 
amongst CXCR3-negative T cells of reporter mice. Overall levels of CD27 expression 
were also lower in T cells from Cxcr3-/- mice (data not shown). CD27 is a member of 
the TNF receptor super family that has been implicated as a T-cell costimulatory 
molecule (44). CD27 expression is thought to characterize naïve or memory T cells, 
whereas loss of CD27 represents terminal differentiation (45). Accordingly, it is 
possible that in addition to controlling T-cell recruitment to sites of infection, Cxcr3-/- 
T cells may undergo terminal differentiation and, possibly, premature Th1 effector 
death in tissues prior to mediating IFN-γ-dependent inflammatory monocyte 
activation. This is consistent with studies showing that CD27low cells are more 
susceptible to apoptosis and that accumulation of influenza-specific T lymphocytes 
was impaired in the lungs of CD27-/- mice during infection (44, 46). In our study, 
CD27 expression was not rescued by adoptive transfer of WT CD4+ T cells (data not 
shown), which may suggest that increasing the T-cell pool allows the system to cross a 
certain threshold of T-cell levels in order to activate inflammatory monocytes without 
reversing CD27 expression.  
 
In the absence of CXCR3, we found that lamina propria neutrophil levels were 
increased during infection, as was their activation status as measured by TNF-α 
expression. Furthermore, adoptive transfer of WT CD4+ T lymphocytes into the KO 
strain reversed increased levels of PMN as well as their production of TNF-α. Because 
this inflammatory cytokine has been linked to intestinal damage during Toxoplasma 
infection (47), it seems likely that CXCR3-dependent effects on neutrophils are likely 
 107
to be secondary to loss of inflammatory monocyte function. In this scenario, defects in 
monocyte-mediated parasite killing would result in damage to the intestinal mucosa. 
Translocation of luminal gut flora, known to contribute to emergence of parasite-
induced intestinal lesions (48-50), would in turn be expected to result in local 
neutrophil recruitment. Indeed, based on neutrophil depletion studies it has been 
suggested that these cells mediate damage to the intestinal mucosa during T. gondii 
infection (27). The cellular and molecular basis for this effect is not at present known, 
but both the IL-17/IL-23 axis and CXCL8 have been shown to promote neutrophil 
accumulation in infected tissues suggesting involvement of one or both of these 
mediators (51-53).          
 
The results of this study extend our understanding of immunity in the intestinal 
mucosa, which has become increasingly important as inflammatory bowel diseases 
(IBD), such as ulcerative colitis and Crohn’s disease, become more common in 
developed regions of the world. In this regard, abnormally high levels of CXCR3 are 
associated with dysregulated intestinal responses in human IBD patients, underscoring 
the potential hazards of unbalanced inflammatory responses (54-56). While CXCR3 
can be pathogenic by recruiting effector cells to otherwise healthy tissue, as in IBD or 
cerebral malaria, we show here that CXCR3-expressing T cells play an essential 
protective role in host defense by enabling defense against pathogenic organisms. 
Antibodies against CXCL10 have been suggested as potential therapeutic agents 
against IBD (57, 58). The results from this study, however, highlight the possible 
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harm of inhibiting CXCR3-expressing cells into sites of inflammation during infection 
with an enteric pathogen.  
 
As the first study to demonstrate a protective role for CXCR3+CD4+ T cells in the 
intestinal immune response, we have shown here that failure to appropriately recruit 
these T cells results in impaired inflammatory monocyte activation, accumulation of 
intestinal parasites, and subsequent recruitment of potentially pathogenic TNF-α-
secreting neutrophils. Our results reveal CXCR3 as a critical chemokine receptor of 
the adaptive immune system that ensures appropriate placement of T cells in inflamed 
tissue, enabling inflammatory monocytes of innate immunity to acquire effector 
functions and mediate effective host defense. 
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Materials and Methods 
Mice and Infections  
Female Swiss Webster mice (6-8 weeks of age) were purchased from the Jackson 
Laboratory (Bar Harbor, ME). Cxcr3-/- and Cxcr3 eGFP knock-in reporter mice (21) 
were established as breeding colonies in the Transgenic Mouse Facility at the Cornell 
University College of Veterinary Medicine. The CXCR3 internal ribosomal entry site 
bicistronic eGFP reporter (CIBER) mice were generated as described (21). This strain 
possesses a functional CXCR3 receptor, and all CXCR3 positive cells also express 
intracellular eGFP. Mouse infections were initiated by oral inoculation of cysts of the 
type II T. gondii ME49 strain. Cysts were isolated from chronically infected Swiss 
Webster mice by homogenization of whole brain in sterile PBS. Unless stated 
otherwise, mice were infected at 8-12 weeks of age with 30 cysts.  
 
Tissue staining and immunofluorescence microscopy  
Intestines were excised, flushed with 10% neutral-buffered formaldehyde, and 
embedded in paraffin for sectioning. Sections were stained for hematoxylin and eosin 
for assessment of pathological changes. Sections were also stained for parasite antigen 
by immunohistochemistry at the Cornell Animal Health Diagnostic Center. Frozen 
sections were obtained by embedding 1 cm lengths of intestine in OCT. Sections of 6-
8µm were cut on a cryostat, fixed in ice-cold acetone, and blocked with PBS 
containing 2X casein and goat serum. To examine T-cell infiltration, sections were 
incubated with rat anti-CD4 antibody (GK1.5) (ATCC, Manassas, VA) or rat IgG at 
4°C overnight followed by goat anti-rat Alexa-647 secondary antibody (Life 
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Technologies, Grand Island, NY). Sections were then mounted in DAPI-Prolong 
antifade (Life Technologies) and imaged by confocal microscopy. ImageJ software 
was used to analyze fluorescence of independent channels. 
 
Cell isolation  
Spleens and mesenteric lymph nodes were excised, crushed between sterile slides, and 
passed through a 70-µm filter (BD, Franklin Lakes, NJ). Red blood cells from 
splenocyte suspensions were lysed with ACK lysis buffer (Life Technologies). For LP 
leukocyte isolation, the small intestine was removed, cleaned of mesentery, flushed 
with sterile PBS, and cleared of Peyer’s patches. The intestine was opened 
longitudinally and the mucosal layer was scraped with a blunt scalpel to remove 
epithelial cells. The tissue was cut into 5 mm sections and vigorously washed with 
Dulbecco’s modified Eagle’s media (Cellgro, Manassas, VA) and 5 mM EDTA (Life 
Technologies). Cells were liberated from the intestinal tissue by digestion with 
10mg/ml collagenase (Sigma, St. Louis, MO) at 37°C and subsequently passed 
through a 70-µm filter. 
 
Cytokine measurement  
Secretion of IFN-γ, TNF-α, and IL-10 was assayed by ELISA (eBioscience, San 
Diego, CA) following manufacturer’s instructions in the presence of soluble 
tachyzoite antigen (STAg) prepared as previously described (59). IL-12p40 was 
quantitated using an in-house ELISA (60). For ileum biopsy cultures, 1 cm intestinal 
sections were flushed with PBS, opened longitudinally, and cultured overnight in 
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complete Dulbecco’s modified Eagle’s media supplemented with 10% bovine growth 
serum (Hyclone), 0.05 mM β-mercaptoethanol (Sigma), 1 mM sodium pyruvate, 0.1 
mM nonessential amino acids, 10,000 U/ml penicillin, 10,000 mg/ml streptomycin, 
and 30 mM HEPES (reagents from Life Technologies). Supernatants were collected 
and assayed for cytokine by ELISA. 
 
Measurement of mRNA by quantitative PCR 
RNA was isolated from MLN and intestinal tissue from mice over a time course of 
infection. Tissue was initially disrupted with a tissue homogenizer and subjected to 
RNA isolation following manufacturer’s instructions (Tissue RNA Kit, Omega 
Biotek, Norcross, GA). RNA was converted to cDNA (Quantas Biosciences, 
Gaithersburg, MD) and assayed for gene expression by SYBR green technology 
(Quanta Biosciences). Primers were designed to span exons by Integrated DNA 
Technologies. GAPDH was used as a housekeeping gene. Gene expression from each 
timepoint was normalized to uninfected control samples. 
 
Flow cytometry   
Single cell suspensions were pelleted and resuspended with primary antibodies 
(BioLegend, San Diego, CA: anti-CD4 PerCP, anti-CD8a APC-Cy7, anti-CD45 
Alexa-488, anti-CD11b APC-Cy7, anti-CD11b APC, anti-Ly6G FITC; eBioscience, 
San Diego, CA: anti-CD25 PE, anti-CD45 APC or FITC, anti-CD69 PE, anti-Ly6C/G 
APC; BD Biosciences, San Jose, CA: anti-Ly6G PE-Cy7, anti-Ly6C V420, anti-CD45 
PE, anti-Ly6C/G PerCP, anti-CD44 APC) in ice-cold FACS buffer (1% bovine serum 
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albumin/0.01% NaN3 in PBS) for 30 min. For IFN-γ staining, cells were incubated for 
6 hrs with Brefeldin-A (eBioscience; 10 ug/ml), PMA (Sigma; 10ng/ml), and 
ionomycin (Sigma; 1ug/ml), then fixed with 4% paraformaldehyde and subsequently 
incubated with primary antibodies resuspended in the FoxP3/transcription factor 
buffer staining set (eBioscience). For IL-12 and TNF-α staining, cells were incubated 
for 6 hrs with Brefeldin-A only (eBioscience). Intracellular staining experiments used 
106 cells. Antibodies used for intracellular staining included anti-IFN-γ PE-Cy7, anti-
TNF-α PE-Cy7 (Biolegend); anti-IL-12 PE, anti-TNF-α APC (BD Biosciences), and 
anti-Toxoplasma p30 (Argene, Shirley, NY). Cell fluorescence was measured using a 
FACS Canto (BD Biosciences). Data was analyzed using FlowJo software (FlowJo, 
Ashland, OR).  
 
Quantitative PCR for parasite burden 
DNA was isolated from whole intestinal tissue using a Tissue DNA kit following 
manufacturer’s instructions (Omega Biotek, Norcross, GA). DNA was amplified by 
quantitative PCR as described previously using primers against the T. gondii B1 gene 
and the host argininosuccinate lyase (ASL) gene (61). Ten-fold serial dilutions of 
genome copy standard curves were created using known quantities of host 
(splenocytes) and parasite (tachyzoites) cells based on DNA quantity, Avogadro’s 
number, and genome size. To quantify parasite burden, the generated values for host 
and parasite genome copies from the DNA preparations were expressed as a ratio of 
parasite (B1) to host (ASL) genomes. 
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Adoptive transfer  
Splenocytes from naïve mice were harvested and subjected to CD4 positive selection 
by magnetic bead sorting following manufacturer’s instructions (Stem Cell 
Technologies, Vancouver, British Columbia). Cells were purified to ~90-95% purity 
and were transferred by intravenous retro-orbital injection into Cxcr3-/- recipients at 
5x106 CD4+ cells per mouse. Twenty-four hours post transfer, mice were challenged 
with 30 cysts of the T. gondii ME49 strain. In some experiments mice were left to 
assess survival following cell transfer. In other experiments intestinal tissue was 
collected at day 9 post-infection for intracellular cytokine analysis.  
 
Pathology scoring 
Swiss rolls of the intestines were histopathologically scored by an investigator that 
was double-blinded to sample identity. Intestines were scored on an ascending 0-4 
scale as previously described (50, 62). Briefly, scores of 0 were normal, scores of 1 
indicated mild focal lesions, scores of 2 indicated moderate focal lesions, scores of 3 
indicated moderate multifocal lesions, and scores of 4 indicated severe multifocal 
lesions. Histopathological features scored included: inflammation of the intestinal 
submucosa (lamina propria), inflammation extending throughout all histological layers 
of the intestine (transmural inflammation), sloughing of intestinal epithelium, 
intestinal villus fusion and blunting, and necrosis of villi. Sections of complete small 
intestines from 13 KO and 14 WT infected mice were scored. The data are plotted as 
mean scores of individual mice.  
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Statistics 
Differences between groups were analyzed using student’s t-test. Differences between 
3 or more groups were analyzed using one-way Anova with Newman-Keuls post-test. 
Survival comparisons were made using a Kaplan-Meier curve (Logrank test). P-values 
less than 0.05 are considered significant and are designated by * p<0.05, ** p<0.01, or 
*** p<0.001. Pathology scores were analyzed using the Mann-Whitney t-test. 
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CHAPTER 4 
 
β-Catenin Signaling Drives Differentiation and Proinflammatory Function of 
IRF8-Dependent Dendritic Cells* 
 
 
 
 
 
 
 
 
*Based on: Cohen, SB, Pepper, M, Shah, S, Yap, GS, Jiang, A, Clausen, BE, Denkers, 
EY. “β-catenin Signaling Drives Differentiation and Proinflammatory Function of 
IRF8-Dependent Dendritic Cells.” In review.  
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Abstract 
Signaling through the Wnt/β-catenin pathway has recently been tied to emergence and 
function of tolerogenic dendritic cells (DC). Here we demonstrate a new role for β-
catenin in directing development of DC subsets through control of cell survival and 
interferon regulatory factor (IRF) 8 activation. DC from mice overexpressing β-
catenin displayed increased proliferation and IRF8 expression, leading to expansion of 
IRF8-dependent CD8α+, plasmacytoid, and peripheral CD103+ DC subsets. As a result 
of increased IRF8 expression, β-catenin stabilized CD8α+ DC secreted elevated levels 
of IL-12 upon in vitro microbial stimulation, and infection of mutant mice with the 
protozoan parasite Toxoplasma gondii led to increased susceptibility associated with 
hypersecretion of IL-12 and Th1-related cytokines. These results reveal a novel 
function for β-catenin in programming DC identity towards pro-inflammatory subsets 
in dependence on IRF8. 
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Introduction 
Dendritic cells (DC) critically bridge innate and adaptive immunity through their 
exquisite capacity to drive antigen-specific T cell activation and effector subset 
differentiation. Furthermore, DC are central players in determining tolerance versus 
immunity during inflammation and infection (1). DC are a heterogeneous population 
of cells with varying surface markers and transcription factor requirements. All DC 
originate from a common bone marrow progenitor, but these cells subsequently 
differentiate into distinct subsets, including monocyte-derived DC (moDC), 
conventional DC (cDC), and plasmacytoid DC (pDC). Many elegant studies have 
identified phenotypic and functional differences amongst these subsets, but identifying 
factors determining control points of DC subset generation is a continuing focus of 
intense interest. Several key cytokines and transcription factors have been implicated 
in controlling DC developmental pathways (2), and recent gene mapping studies have 
begun to elucidate the order in which these factors become expressed (2-5). For 
example, transcription factor Batf3 is involved in generation of splenic CD8α+ DC, 
while IRF4 is important in differentiation of CD11b+CD103+ DC in the intestinal 
lamina propria (6, 7). Recently, Zbtb46 was identified as a global transcription factor 
necessary for generation of cDC (4, 8). Nevertheless, a thorough understanding of the 
mechanisms of DC differentiation and the signals that direct branch points leading to 
distinct subsets remains incomplete. 
 
β-catenin is the primary mediator of the Wnt signaling pathway and is critical for 
numerous cellular functions, including hematopoietic cell fate determination and 
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proliferation (9). Cytosolic β-catenin levels are normally maintained at low levels 
through continual phosphorylation by the serine threonine kinases glycogen synthase 
kinase (GSK)-3β and casein kinase (CK) I-α, which cooperate to promote its 
ubiquitination and proteosomal degradation. Activating Wnt ligands trigger 
disassembly of the complex that coordinates these kinases, leaving β-catenin 
unphosphorylated, in turn enabling nuclear translocation for transcriptional activity in 
association with T cell factor/lymphoid enhancer factor (Tcf/Lef) transcription factors 
(10). While normally associated with embryonic development and tumorigenesis (11), 
β-catenin is increasingly being recognized for its role in immunity (12). This is 
particularly the case for DC, where β-catenin signaling was first implicated in cluster 
disruption-mediated maturation towards a tolerogenic phenotype during in vitro 
culture (13). More recently, β-catenin was found to be involved in the generation or 
maintenance of tolerogenic DC subsets in the intestinal mucosa (1).  
 
Here, we provide surprising new insight into the role of β-catenin in DC function by 
employing transgenic mice with a CD11c-specific deletion in the third exon of the β-
catenin gene (14). The exon 3 fragment encodes the β-catenin amino acid sequence 
that is targeted for GSK-3β-mediated serine threonine phosphorylation and subsequent 
degradation. Removal of this region through Cre-lox mediated excision therefore 
results in phosphorylation-resistant and constitutively active β-catenin (15). We made 
the unexpected discovery that β-catenin stabilization in DC results in selective 
expansion of steady-state levels of splenic CD8α+ DC, pDC, and peripheral CD103+ 
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DC. These DC subsets share in common a dependence on IRF8 for their 
differentiation, and in accordance with this observation, we show that constitutive β-
catenin signaling increases IRF8 expression by these DC subsets. Furthermore, β-
catenin stabilization leads to enhanced proliferation and resistance to apoptosis by 
CD8α+ DC. We employed infection with the intracellular pathogen Toxoplasma 
gondii as a model to determine the in vivo consequences of DC-specific β-catenin 
stabilization. Control of T. gondii is well known to require robust Th1 activation (16, 
17), and IL-12 produced by splenic CD8α+ DC has recently been shown to play an 
essential role in this response (18). Nevertheless, production of IL-12 and other 
proinflammatory cytokines is lethal if not modulated by endogenous mediators (19, 
20). Indeed, exon 3-deleted mice were highly susceptible to infection, and this was 
associated with elevated levels of CD8α+ DC IL-12 secretion and increased Th1 IFN-γ 
production. Our results uncover a new role for β-catenin in controlling IRF8 
expression in DC, thereby revealing this transcription factor as a key player regulating 
IRF8-driven DC differentiation and proinflammatory function. 
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Results 
β-catenin stabilization expands splenic CD8α+ and plasmacytoid dendritic cell 
populations 
To determine the role of β-catenin signaling in dendritic cell differentiation and 
function, mice floxed for exon 3 of the β-catenin gene were crossed with CD11c-cre 
animals, resulting in Cre-positive progeny whose CD11c+ cells possessed an exon 3-
deleted β-catenin form resistant to phosphorylation-induced degradation (14, 15). 
Flow cytometric analysis of CD11c+ splenic DC from Cre-positive offspring (Ex3DC-/- 
mice) demonstrated high β-catenin expression levels compared to Cre-negative 
littermate controls (Ex3fl/fl mice) (Figure 4.1A), indicating accumulation of β-catenin 
protein upon exon 3 deletion. This was confirmed to be specific to CD11c+ cells, as 
CD4+ T cells from Ex3DC-/- mice did not display upregulation of β-catenin compared 
to CD4+ T cells from Ex3fl/fl mice (Figure 4.1B). Furthermore, upon cytoplasmic and 
nuclear fractionation, Ex3DC-/- bone marrow-derived DC (BMDC) were found to be 
enriched for a truncated form of nuclear β-catenin compared to Ex3fl/fl DC, confirming 
enhanced nuclear translocation of protein (Figure 4.1C). Thus, CD11c-directed exon 3 
deletion results in β-catenin accumulation and nuclear translocation in dendritic cells.  
 
We next examined the outcome of β-catenin stabilization on tissue resident DC. We 
first observed that the percentage and total number of DC (CD11c+MHCII+ cells) were 
unaffected in Ex3DC-/- mice (Figure 4.2A-C). However, further analysis revealed a 
striking expansion of the CD8α+ DC subset and a concomitant decrease in CD11b+ 
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DC (Figure 4.2D-H). Furthermore, plasmacytoid DC (pDC), as defined by expression 
of B220 and PDCA-1, were also expanded in the spleens of Ex3DC-/- mice (Figure 4.2I-
K). These collective data suggest that β-catenin exerts major effects on the generation 
or stability of splenic tissue resident DC populations. Therefore, employing wild-type 
(WT) mice as a source of cells, we assessed β-catenin levels in CD8α+ and pDC 
splenic populations. We found that these subsets displayed strikingly higher β-catenin 
levels compared to CD8α- and PDCA-1- populations (Figure 4.2L and M). These data 
lead us to conclude that β-catenin stabilization in DC promotes the expansion of 
CD8α+ DC and pDC.  
 
The CD8α+ DC subset is developmentally and functionally related to CD103-
expressing DC found in non-lymphoid peripheral tissues, such as the intestine and the 
lung (15, 21). Further examination of Ex3DC-/- mice revealed a striking expansion of 
intestinal CD103+CD11b- cells but not CD103+CD11b+ cells (Figure 4.3A-C). 
Additionally, lung resident CD103+CD11b- DC were also expanded in Ex3DC-/- mice 
compared to Ex3fl/fl littermate controls (Figure 4.3D and E). These results demonstrate 
the capacity of β-catenin to drive the differentiation of peripheral tissue DC that share 
developmental pathways with splenic CD8α+ DC. 
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Figure 4.1. Ex3DC-/- mice display DC-specific accumulation and nuclear 
translocation of β-catenin. (A) Single cell suspensions were prepared for flow 
cytometry from naïve Ex3fl/fl and Ex3DC-/- spleens, and intracellular β-catenin 
expression was assessed after gating on CD11c+ cells. (B) Intracellular β-catenin 
levels in splenic CD4+ T cells isolated from Ex3fl/fl and Ex3DC-/- mice. (C) Bone 
marrow-derived DC from Ex3fl/fl and Ex3DC-/- mice were subjected to cytoplasmic (C) 
and nuclear (N) fractionation, and resulting lysates were probed for β-catenin protein 
expression. Antibodies against PARP and Rab5 were used for nuclear and cytoplasmic 
loading controls, respectively. 
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Figure 4.2. β-catenin stabilization expands splenic CD8α+ and plasmacytoid DC 
populations. (A-K) Single suspensions were prepared from naïve Ex3fl/fl and Ex3DC-/- 
splenocytes and stained for CD11c, MHCII, CD8α, CD11b, PDCA-1, and B220 for 
DC surface marker expression analysis by flow cytometry. (A-C) Percentage and total 
number of CD11c+MHCII+ cells in Ex3fl/fl and Ex3DC-/- spleens. Percentage and total 
number of (D-F) CD8α+ DC and (D,G-H) CD11b+ DC  in naïve Ex3fl/fl and Ex3DC-/- 
spleens. (I-K) Percentage and total number of B220+PDCA-1+ plasmacytoid DC in 
naïve Ex3fl/fl and Ex3DC-/- spleens. (L and M) Splenocytes isolated from wild-type 
mice were surface stained for CD11c and CD8α (L) or PDCA-1 and B220 (M) and 
were intracellularly stained for β-catenin. Median fluorescent intensity (MFI) of β-
catenin expression among different DC subsets is shown. Dots in relevant graphs 
represent results from single mice. Bar graphs display means and standard errors of 
individual mice. In this figure, * p<0.05; ** p<0.01; *** p<0.001.  
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Figure 4.3 β-catenin drives the expansion of peripheral CD103+ DC. (A-C) Single 
cell suspensions were prepared from naïve Ex3fl/fl and Ex3DC-/- intestinal tissue 
following collagenase digestion and stained for CD11c, CD103, and CD11b by flow 
cytometry. (A) Plots from representative mice and percentages of CD103+CD11b- (B) 
and CD103+CD11b+ (C) intestinal DC for multiple mice are shown. (D and E) Single 
cell suspensions were prepared from naïve Ex3fl/fl and Ex3DC-/- lung tissue and stained 
for CD11c, CD103, and CD11b for flow cytometric analysis of DC surface marker 
expression. (D) Plots from representative mice and (E) percentage of CD103+CD11b- 
lung DC for multiple mice are shown. Each dot represents an individual mouse. In this 
figure, ** p<0.01. 
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Effect of β-catenin stabilization on maintenance of steady state DC   
β-catenin regulates proliferation, apoptosis, and cell survival in many cell types, 
including hematopoietic stem cells and regulatory T cells, but its effects on DC are not 
known (22, 23). To address whether β-catenin affected proliferation of DC, naïve 
Ex3fl/fl and Ex3DC-/- mice were injected intraperitoneally with BrdU, and BrdU labeling 
of splenic DC was measured after 4 hr. Consistent with a role for β-catenin in 
promoting proliferation, S phase occupancy, as measured by BrdU uptake, was 
significantly increased in CD8α+ and CD8α- DC from Ex3DC-/- mice compared to 
Ex3fl/fl littermate controls (Figure 4.4A-C). To measure survival, splenocytes were 
assayed for apoptosis and cell death by simultaneously labeling with a viability dye 
and Annexin V. CD8α+ DC from Ex3DC-/- mice displayed decreased Annexin V 
staining (Annexin V+, Live/Dead-) as well as decreased overall cell death (Annexin V+, 
Live/Dead+) compared to Ex3fl/fl littermate controls, indicating a potential increase in 
cell survival due to reduced apoptosis (Figure 4.4D-E). Interestingly, Ex3DC-/- CD8α- 
DC of both genotypes equally labeled with Annexin and viability dye, suggesting β-
catenin signaling specifically prevented apoptosis in CD8α+ DC (Figure 4.4D and F). 
Therefore, β-catenin stabilization results in increased cell proliferation and decreased 
apoptosis of splenic CD8α+ DC.  
 
β-catenin signaling controls Irf8 expression 
Genetic knockout and gene mapping studies have identified several transcription 
factors involved in CD8α+ DC differentiation, including Id2, Nfil3, Batf3, and Irf8 (5, 
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6, 24-27). Therefore, we determined the effect of β-catenin stabilization on expression 
of these transcription factors in CD11c+ splenocytes from Ex3fl/fl and Ex3DC-/- mice. 
While there was no significant difference in Id2 expression, Nfil3 and Batf3 transcripts 
were slightly increased albeit in a statistically non-significant manner (Figure 4.5A). 
However, there was a striking increase in Irf8 expression in the CD11c compartment 
upon β-catenin stabilization (Figure 4.5A). We then assessed IRF8 protein expression 
in CD8α- and CD8α+ splenic DC in Ex3fl/fl and Ex3DC-/- mice by flow cytometry. 
Levels of IRF8 were relatively low in CD8α- DC from both mouse strains. However, 
there was an increase in IRF8 median fluorescence intensity (MFI) in CD8α+ DC in 
both mouse strains (Figure 4.5B and C). Furthermore, IRF8 MFI and percent positive 
populations were increased when comparing CD8α+ DC from Ex3DC-/- relative to 
Ex3fl/fl strains (Figure 4.5C and D). To confirm that the effect of β-catenin 
stabilization was specific for IRF8, we examined expression of IRF4 and found it to be 
unchanged in Ex3DC-/- relative to Ex3fl/fl CD8α+ splenic DC (Figure 4.5E). Consistent 
with this finding, levels of intestinal CD103+CD11b+ DC and splenic CD4+ DC, which 
are both known to depend on IRF4 for development (7, 28), were unchanged between 
Ex3fl/fl and Ex3DC-/- mice (Figure 4.3C and 4.5F-G). 
 
To show a direct effect of β-catenin signaling on IRF8 expression, WT BMDC were 
cultured with the Wnt/β-catenin inhibitor ICG-001, which competes with β-catenin for 
binding to its co-factor Creb-binding protein (CBP) (29). Confirming inhibition of the 
Wnt/β-catenin pathway, transcript levels of the known β-catenin target gene Axin2 
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were significantly diminished following 5 hr of culture with ICG-001 (30) (Figure 
4.5H). Furthermore, Irf8 transcripts were significantly reduced following ICG 
treatment. This downregulation was also observed at the protein level, as IRF8 
expression in BMDC was markedly decreased compared to DMSO-treated control 
cells by flow cytometry, but as expected, there was no effect on total β-catenin 
expression (Figure 4.5I). IRF4 levels were unchanged by ICG-001 treatment, 
confirming the specificity of β-catenin signaling for IRF8 (data not shown). These 
data establish a functional link between β-catenin and IRF8 expression. The finding 
that β-catenin controls IRF8 expression is in line with our observation that CD8α+ DC, 
pDC, and CD103+ tissue DC are increased in Ex3DC-/- mice, insofar as IRF8 is 
implicated in DC differentiation towards both CD8α+ and pDC subsets (31), and is 
consistent with the finding that IRF8, but not Id2, Nfil3, or Batf3, is essential for 
CD8α+ DC development (32).  
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Figure 4.4. Effect of β-catenin stabilization on maintenance of steady state DC. 
(A-C) Ex3fl/fl and Ex3DC-/- mice were injected i.p. with 2 mg bromodeoxyuridine 
(BrdU), and splenocytes were isolated 4 hr later. (A) Representative FACS plots of 
CD8α+ DC from Ex3fl/fl and Ex3DC-/- mice following BrdU injection. Percentage of 
Ex3fl/fl and Ex3DC-/- CD8α+ (B) and CD8α- (C) DC occupying S phase (Ex3fl/fl, n=11; 
Ex3DC-/-, n=8). (D-F) Splenocytes were prepared from naïve Ex3fl/fl and Ex3DC-/- mice 
and were co-labeled with viability dye and Annexin V. (D) Representative FACS plots 
of CD8α+ and CD8α- DC from Ex3fl/fl and Ex3DC-/- mice. Percentage of Ex3fl/fl and 
Ex3DC-/- CD8α+ (E) and CD8α- (F) DC that are apoptotic (AnnexinV+; Live/Dead-) or 
non-viable (Annexin V+; Live/Dead+) (Ex3fl/fl, n=4; Ex3DC-/-, n=3). In this figure, 
means and standard errors of individual mice are shown, where * p<0.05; ** p<0.01.  
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Figure 4.5. β-catenin signaling controls Irf8 expression. (A) RNA was isolated 
from CD11c+ splenocytes from naïve Ex3fl/fl and Ex3DC-/- mice (n=3 per strain), and 
mRNA levels of Nfil3, Batf3, Id2, and Irf8 were determined by semi-quantitative real-
time PCR amplification and normalized to GAPDH expression. (B) IRF8 expression 
by Ex3fl/fl and Ex3DC-/- CD8α- and CD8α+ splenic DC as determined by flow 
cytometry. The median fluorescent intensity (MFI) of IRF8 within Ex3fl/fl and Ex3DC-/- 
CD8α- and CD8α+ DC (C) and the percentage of CD8α+ DC expressing IRF8 (D) are 
shown. (E) Ex3fl/fl and Ex3DC-/- CD11c+ splenocytes were evaluated for intracellular 
IRF4 expression and MFI. (F-G) CD8α-CD4+ splenic DC were quantified from Ex3fl/fl 
and Ex3DC-/- mice. Representative FACS plots (F) and the means and standard errors of 
CD4+ DC levels for multiple mice (G) are shown (Ex3fl/fl, n=16; Ex3DC-/-, n=14). (H-I) 
Bone marrow-derived DC were cultured with vehicle alone (DMSO) or 5 µM of the 
Wnt/β-catenin inhibitor ICG-001 for 5 hr. (H) RNA was isolated from cultured 
BMDC, and Irf8 and Axin2 transcript levels were assessed by quantitative PCR. Fold 
change is relative to DMSO control. (I) Intracellular expression of IRF8 and β-catenin 
were then assessed by flow cytometry. One representative of 4 independent 
experiments is shown. In this figure, * p<0.05; ** p<0.01; *** p<0.001.  
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Regulatory T cells are expanded upon DC-specific β-catenin stabilization 
CD8α+ DC and DC-specific β-catenin expression have both been implicated in 
controlling Treg development and tolerance (1, 13, 33). To examine if β-catenin-
stabilized DC have the capacity to promote tolerogenic T cell accumulation, splenic 
Treg levels were quantified in Ex3fl/fl and Ex3DC-/- mice. There was an approximately 
two-fold increase in the peripheral Treg population in spleens of Ex3DC-/- mice 
compared to littermate controls both with regards to percentage and total Treg 
numbers (Figure 4.6A and B; data not shown). Furthermore, this phenotype was also 
apparent in natural Treg, as thymic Treg levels were similarly expanded in Ex3DC-/- 
mice (Figure 4.6A and B). These data indicate that β-catenin stabilization in DC 
promotes their effectiveness at inducing both natural and inducible Treg populations.  
 
β-catenin stabilization enhances IL-12 production by CD8α+ DC  
TLR signaling most often leads to the secretion of cytokines via the induction of 
NFκB transcription factors (34). However, CD8α+ DC were recently shown to require 
IRF8 rather than NFκB for the induction of IL-12 in response to the Toxoplasma 
gondii actin polymerizing protein profilin, occurring in dependence upon TLR11/12 
signaling (35). Additionally, while LPS signaling is mediated through TLR4-
dependent NFκB activation, LPS has been shown to upregulate Irf8 expression and 
promote its binding to the IL-12 promoter (36, 37). Therefore, we wanted to determine 
if overexpression of IRF8 in CD8α+ DC from Ex3DC-/- mice would impact their 
functional activity, in particular as related to IL-12 production.  
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To examine this, whole splenocytes from Ex3fl/fl and Ex3DC-/- mice were cultured in the 
presence of media, LPS, or soluble tachyzoite antigen (STAg), an antigenic 
preparation of T. gondii that contains profilin. Indeed, upon LPS or STAg stimulation, 
supernatants from Ex3DC-/- splenocytes contained significantly increased levels of IL-
12p40 compared to Ex3fl/fl controls (Figure 4.7A). To confirm that the source of IL-12 
was DC, CD11c+ cells were magnetically purified from Ex3fl/fl and Ex3DC-/- 
splenocytes and cultured with LPS and STAg. As expected, increased IL-12 secretion 
was again observed in Ex3DC-/- cells, establishing that DC were the source of enhanced 
IL-12 production (Figure 4.7B). These results clearly show that DC from Ex3DC-/- 
produce more IL-12 than cells from wild-type littermates. However, they leave open 
to question whether this is a result of an increase in the proportion of CD8α+ DC, or 
whether Ex3DC-/- CD8α+ DC produce increased IL-12 on a cell-to-cell basis relative to 
corresponding cells from Ex3fl/fl mice. Therefore, CD8α+ and CD8α- DC were 
magnetically purified from Ex3fl/fl and Ex3DC-/- spleens and stimulated in vitro with 
STAg. While IL-12 production was restricted to the CD8α+ subset, the Ex3DC-/- 
CD8α+ DC secreted enhanced IL-12 levels compared to Ex3fl/fl CD8α+ DC (Figure 
4.7C). Next, WT splenocytes were treated with ICG-001 and then stimulated with 
STAg or LPS overnight. Inhibitor-treated cells secreted lower levels of IL-12p40 
compared to DMSO-treated cells without negatively affecting viability (Figure 4.7D 
and data not shown). Furthermore, the elevated IL-12 secretion displayed by Ex3DC-/- 
splenocytes over Ex3fl/fl splenocytes could be inhibited by treatment with ICG-001, 
further indicating that ICG-001 treatment suppresses β-catenin-dependent responses 
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(Figure 4.7E). Thus, β-catenin stabilization promotes both differentiation and IL-12-
secreting capacity of CD8α+ DC by promoting increased Irf8 expression. 
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Figure 4.6 Regulatory T cells are expanded upon DC-specific β-catenin 
stabilization. (A) Single cell suspensions were prepared from naïve Ex3fl/fl and Ex3DC-
/- splenocytes and thymocytes, and Foxp3 expression was assessed amongst CD4+ T 
cells by flow cytometry to determine proportion of inducible and natural regulatory T 
cells (Treg), respectively. (B) The means and standard errors of natural and inducible 
Treg levels in splenocytes and thymocytes from individual mice. (Spleen: Ex3fl/fl: n=5 
Ex3DC-/-: n=5; Thymus: Ex3fl/fl: n=3; Ex3DC-/-: n=3). In this figure, *** p<0.001. 
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Figure 4.7. β-catenin stabilization enhances IL-12 production by CD8α+ DC. (A) 
Naïve Ex3fl/fl and Ex3DC-/- splenocytes were stimulated in vitro with LPS (100 ng/ml), 
STAg (50 mg/ml), or media, and IL-12 was measured in the supernatants by ELISA. 
Ex3fl/fl, n=3; Ex3DC-/-, n=5. (B) CD11c+ DC were purified from Ex3fl/fl and Ex3DC-/- 
splenocytes and stimulated in vitro with LPS, STAg, or media. IL-12 levels were 
measured from supernatants by ELISA. (C) CD8α+ DC were purified from naïve 
Ex3fl/fl and Ex3DC-/- splenocytes, and CD8α+ and CD8α- DC were stimulated in vitro 
with media or STAg for 48 hr. IL-12 was measured from the supernatants by ELISA. 
(D and E) IL-12 secretion was measured from supernatants of Ex3fl/fl (D) and Ex3DC-/- 
(E) splenocytes cultured with ICG-001 or DMSO for 5 hr and then stimulated 
overnight with STAg or LPS. One representative mouse of 5 with similar results is 
shown. In this figure, * p<0.05; ** p<0.01.  
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Constitutive DC β-catenin signaling renders mice susceptible to Toxoplasma 
gondii infection 
To evaluate the impact of DC β-catenin stabilization on host immunity, we utilized 
intraperitoneal infection with T. gondii. CD8α+ DC are required for parasite control in 
this model as a source of protective IL-12 (18), yet overexpression of proinflammatory 
molecules is also lethal (19). The selective increase in CD8α+ DC in Ex3DC-/- mice 
was maintained after infection, although there was an approximately 5-fold increase in 
absolute numbers of each population (Figure 4.8A and B, compare to Figure 4.2F). 
The Ex3DC-/- mice began to succumb within 9 days of low dose T. gondii 
intraperitoneal infection, while the Ex3fl/fl littermate controls fully survived acute 
infection (Figure 4.9A). There was no difference in survival of Ex3fl/fl and Ex3DC-/- 
mice following oral infection with a lethal dose of T. gondii (50 cysts) (Figure 4.9B); 
however, Ex3DC-/- mice were more susceptible to oral infection with a low dose of 
parasite (20 cysts) (Figure 4.9C). Parasite levels in the spleen (Figure 4.9D and E) and 
peritoneal cavity (Figure 4.9E) were equivalent between the genotypes following low 
dose i.p. infection, arguing that susceptibility of Ex3DC-/- mice was not due to defective 
control of Toxoplasma.  
 
Since naïve Ex3DC-/- splenic DC displayed increased IL-12 production during in vitro 
STAg stimulation, we examined the status of splenic DC IL-12 production during in 
vivo infection. CD11c+ DC were magnetically purified from Day-6 infected Ex3fl/fl 
and Ex3DC-/- mice and cultured without additional stimulation. Indeed, splenic DC 
from infected Ex3DC-/- mice secreted dramatically more IL-12 compared to Ex3fl/fl 
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controls as measured by both p40 (Figure 4.9F) and p70 (Figure 4.9G) subunits and, at 
nearly 50 ng/ml, the levels detected in Ex3DC-/- mice were approximately 5-fold over 
WT controls  (Figure 4.9G). Consistent with observations in naïve DC, DC from 
infected Ex3DC-/- mice also displayed increased IRF8 expression compared to Ex3fl/fl 
littermate controls (Figure 4.8C). To examine Th1 skewing in these animals at the 
peak of T. gondii infection, Ex3fl/fl and Ex3DC-/- splenocytes from Day 9-infected mice 
were cultured in vitro, and the supernatants were assayed for both IL-12 and IFN-γ. 
Accompanying increased IL-12 secretion by Ex3DC-/- splenocytes, IFN-γ levels were 
enhanced, suggesting elevated T and possibly NK cell activation in Ex3DC-/- mice in 
response to T. gondii infection (Figure 4.9H). Furthermore, serum collected from mice 
9 days post-infection revealed significantly elevated levels of IFN-γ, IL-12, and TNF-
α in Ex3DC-/- mice compared to Ex3fl/fl controls (Figure 4.9I), suggesting systemic 
hyperproduction of potentially lethal cytokines upon DC β-catenin stabilization.  
 
The observation that infection of Ex3DC-/- mice led to IL-12 overproduction raised the 
question of why elevated Treg cells that we observed (Figure 4.6) did not exert an 
immunomodulatory effect. However, we found that while Treg were elevated in non-
infected Ex3DC-/- mice, over the course of infection the population collapsed to that 
found in WT mice (Figure 4.8D). The collapse in Treg populations is consistent with 
previous studies (38, 39), and the data here show that this phenomenon occurs even in 
the presence of DC β-catenin stabilization that promotes CD8α+ DC expansion.  
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 Figure 4.8. Influence of infection on levels of splenic CD8α+ DC and Treg 
populations in Ex3DC-/- mice. (A-C) Ex3fl/fl and Ex3DC-/- mice were i.p. infected with 
25 ME49 T. gondii cysts, and splenocytes were harvested 6 (A and B) or 9 (C) days 
post-infection. The percentage (A) and total number (B) of CD8α+ DC was 
determined in Ex3fl/fl and Ex3DC-/- spleens during infection. The means and standard 
errors are shown, and each dot represents an individual mouse. (C) IRF8 expression 
was compared between Ex3fl/fl and Ex3DC-/- splenic CD8α+ DC during infection. (D) 
Ex3fl/fl and Ex3DC-/- mice were infected (25 ME49 T. gondii cysts), and levels of 
splenic regulatory T cells (Treg), as defined by CD4 and FoxP3 expression, were 
evaluated by flow cytometry over a time course of infection. 
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Figure 4.9. Constitutive DC β-catenin signaling renders mice susceptible to 
Toxoplasma infection. (A) Ex3fl/fl and Ex3DC-/- mice were i.p. injected with the 
Toxoplasma Type II strain ME49 (25 cysts), and survival was monitored. (B and C) 
Ex3fl/fl and Ex3DC-/- mice were orally infected with 50 (B) or 20 (C) ME49 T. gondii 
cysts, and survival was monitored. (D) DNA was isolated from Ex3fl/fl and Ex3DC-/- 
spleens 9 days post-infection, and parasite (B1 gene) and host DNA (ASL gene) were 
amplified by quantitative real-time PCR to determine parasite burden. Parasite load is 
displayed as a ratio of parasite genomes to host genomes (Ex3fl/fl, n=4; Ex3DC-/-, n=3). 
(E) Parasite burden was measured from the spleens and peritoneal cavities of Day-6 
post-infection mice by flow cytometry using an antibody against T. gondii SAG-1 
(p30) (Spleen, Ex3fl/fl, n=3; Ex3DC-/-, n=4. PEC, Ex3fl/fl, n=9; Ex3DC-/-, n=14). (F) 
CD11c+ DC were purified from Day-6 post-infection splenocytes, and DC were 
cultured overnight without additional stimulation. IL-12p40 was measured from the 
supernatants by ELISA. (G) Splenocytes from Day-6 post-infection mice were 
cultured without additional stimulation for 72 hr, and supernatants were assayed for 
IL-12p70 (Ex3fl/fl, n=3; Ex3DC-/-, n=5). (H) Splenocytes from Day-10 post-infection 
mice were cultured without additional stimulation for 72 hr, and supernatants were 
assayed for IL-12p40 and IFN-γ by ELISA (n=3 per strain). (I) Serum was collected 
from Day-9 post-infection mice and assayed for IL-12p40, IFN-γ, and TNF-α by 
ELISA (n=3 per strain). The means and standard errors of individual mice are shown, 
where * p<0.05; ** p<0.01.  
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CD4+ T cells and NK cells, but not CD8+ T cells, overproduce IFN-γ  following 
infection in mice with constitutive DC β-catenin signaling 
To determine the source of elevated Th1 cytokines in Ex3DC-/- mice during T. gondii 
infection, IFN-γ production by splenic CD4+ T cells, CD8+ T cells, and natural killer 
(NK) cells was assayed 8 days post-infection. Both CD4+ T cells and NK cell 
populations in Ex3DC-/- mice displayed a marked increase in IFN-γ responses compared 
to Ex3fl/fl littermate controls (Figure 4.10A and C). Interestingly, given previous 
studies implicating CD8α+ DC in cross-presentation (6, 18, 40), IFN-γ from CD8+ T 
cells was not significantly changed between the two genotypes (Figure 4.10B).  
 
We also asked whether T cells activated in the Ex3DC-/- environment showed signs of 
increased activation. However, we detected no difference in the expression of markers 
of proliferation (Ki67) on CD4+ and CD8+ T cells during infection (Figure 4.11A) or 
in expression of the costimulatory molecules CD80 and CD86 on DC (data not shown). 
In support of this, OVA-pulsed splenic DC from Ex3fl/fl and Ex3DC-/- mice stimulated 
equivalent OT-II CD4+ T cell proliferation in vitro (Figure 4.11B).   
 
We next determined whether the increase in the CD4+ T cell IFN-γ-positive population 
could be explained by increased activation and expansion of Toxoplasma-specific T 
cells.  We used MHCI tetramers that bind to CD8+ T lymphocytes specific for the 
endogenous T. gondii epitope Tgd057 and MHCII tetramers that bind to CD4+ T cells 
specific for the Toxoplasma epitope CD4Ag28m (41, 42). As shown in Figures 4.10D 
and E, the frequency of parasite-specific CD4+ and CD8+ T cells was equivalent in 
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Ex3DC-/- and Ex3fl/fl mice. Furthermore, while tetramer-positive cells of both genotypes 
demonstrated enhanced IFN-γ secretion over tetramer-negative cells, antigen-specific 
CD4+ T cells from Ex3DC-/- mice secreted markedly higher levels of IFN-γ relative to 
Ex3fl/fl counterparts (Figure 4.10F and G).  
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Figure 4.10. CD4+ T cells and NK cells, but not CD8+ T cells, overproduce IFN-
γ  following infection in mice with constitutive DC β-catenin signaling. (A-C) 
Single cell suspensions were prepared from Ex3fl/fl and Ex3DC-/- spleens 9 days post-
infection, and cells were cultured in the presence of PMA, ionomycin, and Brefeldin-
A for 4 hr. Cells were surface stained for CD4 (A), CD8 (B), or NK1.1 (C) and 
intracellularly stained for IFN-γ. Shown are representative contour plots of individual 
mice and the mean ± standard error of IFN-γ levels from multiple mice. (D-G) 
Splenocyte single cell suspensions from Day 9-infected Ex3fl/fl and Ex3DC-/- mice were 
surface stained with tetramers specific for the MHC class II T. gondii epitope 
CD4Ag28m (D) and the MHC class I epitope Tgd057 (E) recognized by parasite-
specific CD4+ and CD8+ T cells, respectively, to assess antigen-specific T cell priming. 
Tetramer-positive CD4+ (F) and CD8+ (G) T cells were then assessed for IFN-γ levels 
following 4 hr of culture with PMA, ionomycin, and Brefeldin-A (Ex3fl/fl, n=3; Ex3DC-
/-, n=3). Means and standard errors of individual mice are shown, and each dot 
represents a single mouse. In this figure, * p<0.05; *** p<0.001.  
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Figure 4.11. Constitutive DC β-catenin signaling does not influence antigen-
specific T cell proliferative responses. (A) Ex3fl/fl and Ex3DC-/- mice were infected i.p. 
with 25 ME49 T. gondii cysts, and spleens were harvested after 6 days. Splenocytes 
were surface stained for CD4 or CD8 and intracellularly for Ki67 to assess T cell 
proliferation by flow cytometry. (B) Splenic DC were magnetically sorted from naïve 
Ex3fl/fl and Ex3DC-/- mice and pulsed with OVA peptide for 4 hr. OVA-pulsed DC (105) 
were then co-cultured with CFSE-labeled OT-II CD4+ T cells for 72 hr (2.5: 1 T cell: 
DC). CFSE dilution was examined by flow cytometry to determine T cell proliferation.  
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Discussion 
Dendritic cell differentiation is a complex process involving an array of transcription 
factors and growth factor cytokines whose details are continuing to be elucidated. In 
this study we identify an unexpected role for β-catenin in controlling expansion of 
CD8α+ DC, pDC, and developmentally related non-lymphoid CD103+ DC. This 
pattern of transcriptional control precisely matches that of IRF8 (2, 21, 25, 28, 31). In 
support of a functional connection between β-catenin and IRF8, overexpression of β-
catenin increased steady state IRF8 levels in CD8α+ DC. In addition, IL-12 production 
by CD8α+ DC, a known function of this cell subset, was prevented by β-catenin 
inhibition concomitant with IRF8 down-modulation, and CD8α+ DC overexpressing 
β-catenin produced enhanced IL-12 in response to microbial stimulation. During 
infection with T. gondii, a prototypic Th1-inducing pathogen, mice overexpressing 
DC-specific β-catenin developed exacerbated proinflammatory cytokine responses 
culminating in early death. Consistent with established roles for β-catenin in other cell 
types, such as hematopoietic stem cells and regulatory T cells (22, 23), β-catenin 
stabilization also resulted in increased proliferation and resistance to apoptosis by 
CD8α+ splenic DC, suggesting a potential two-pronged mechanism of β-catenin-
dependent CD8α+ DC expansion. 
 
Our data are notable because other recent studies have implicated β-catenin signaling 
in promoting tolerogenic DC phenotypes. For example, in contrast to activation by 
microbial stimulation, cluster disruption of bone marrow-derived DC activates β-
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catenin, endowing the cells with the ability to promote regulatory T cells that protect 
against experimental autoimmune encephalitis (13, 43). In the intestine, β-catenin 
expression by CD11c+ cells was shown to be required for regulatory T cell induction 
and production of anti-inflammatory factors, including retinoic acid-metabolizing 
enzymes, TGF-β, and IL-10 (1). In this case, absence of β-catenin in DC increased 
sensitivity to dextran sodium sulfate-mediated colitis. Along parallel lines, DC-
specific β-catenin expression is also involved in tumor-mediated inhibition of CD8+ T 
cell cross priming (14). Our data uncover an important new facet of β-catenin 
signaling because they reveal a role in promoting the differentiation and survival of 
IRF8-dependent CD8α+ DC with enhanced proinflammatory activity. Consistent with 
our findings, a recent study also identified a functional link between Wnt/β-catenin 
and IRF8 in leukemia progression, whereby Tcf/Lef1 transcription factors can directly 
bind the Irf8 promoter at one of three consensus bindings sites, providing an 
independent line of evidence for the importance of this previously unappreciated 
signaling axis (44).  
 
Although our findings reveal an overall proinflammatory effect of DC-specific β-
catenin activation, our findings are also concordant with earlier studies insofar as DC-
specific β-catenin stabilization increased steady state levels of Foxp3+ Treg. 
Consistent with the expansion of CD8α+ DC in our model, these cells have been 
implicated in the induction of Treg (33). We hypothesized that the induction of Treg 
by DC β-catenin stabilization would result in protection from the T. gondii-mediated 
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intestinal inflammation that follows high dose oral infection (45). Surprisingly, Ex3DC-
/- mice were equally susceptible to high dose infection with Toxoplasma and were 
more susceptible to both oral and intraperitoneal low dose infections that are normally 
non-lethal. In fact, the expanded steady-state Treg population is unlikely to impact 
control of T. gondii because infection induces rapid collapse of this T cell subset, as 
was observed by us in the present study and previously by others (38, 39). Therefore, 
by its unique property of minimizing Treg numbers, T. gondii infection exposed a 
novel inflammatory role for β-catenin that was likely concealed by experimental 
models in which Treg, play a functional role, such as DSS colitis and EAE (1, 13). It 
will be interesting to investigate whether Ex3DC-/- mice are protected from pathologies 
that can be prevented by Treg in future studies.      
 
Several lines of evidence indicate a role for CD8α+ DC in antigen cross presentation 
and activation of CD8+ T lymphocytes (6, 40, 46). Toxoplasma is well known for its 
ability to elicit potent CD8+ T cell responses, and cross presentation has previously 
been found to play a role in MHC class I presentation to CD8+ T cells during infection 
with this intracellular protozoan (47-49). Therefore, it was initially surprising that 
there was no indication of abnormally strong CD8+ T cell responses in infected Ex3DC-
/- mice that overexpress CD8α+ DC. However, the recent discovery that the parasite 
directly injects a subset of secretory proteins into the host cell cytoplasm (50-52), as 
well as evidence that the majority of T cell activation is stimulated by actively infected 
DC (53), argues that conventional presentation rather than cross presentation may be 
the dominant mechanism for CD8+ T cell priming.       
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In contrast to normal CD8+ T cell responses in mice with DC-specific β-catenin 
activation, there was a clear increase in CD4+ T cell, and to a lesser extent NK cell, 
IFN-γ production after infection of the mutant mice. This is of interest because CD4+ 
and CD11b+ DC, which are believed to be the most adept at activating CD4+ T cells 
(54, 55), were unchanged or even reduced in Ex3DC-/- mice. While it seems most likely 
that increased CD4+ T and NK cell IFN-γ results from increased splenic CD8α+ DC 
activity, we cannot at this point exclude a role for pDC that are also increased. Indeed, 
pDC have previously been shown to present antigen and produce IL-12 during 
Toxoplasma infection (56). We also found that pDC are preferentially targeted for 
infection in the spleen (57). Finally, we cannot exclude the possibility that CD11c+ 
inflammatory monocytes might mediate increased CD4+ T cell activation upon β-
catenin stabilization. Regardless of these uncertainties, our data demonstrate that β-
catenin signaling underlies IRF8-dependent differentiation and function of DC subsets.   
 
Our findings uncover for the first time a role for stabilized β-catenin signaling in 
promoting DC subset differentiation and activity. Based upon previous findings, it has 
been suggested that exploiting strategies that activate β-catenin signaling in DC might 
be useful in the control of inflammatory and autoimmune diseases (1, 13). Our study 
throws a cautionary light on this approach, showing that constitutive β-catenin 
signaling alters the steady state DC differentiation program by acting through IRF8 to 
skew these cells towards a proinflammatory phenotype.  
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Materials and methods 
Ethics statement 
All experiments in this study were performed strictly according to the 
recommendations of the Guide for the Care and Use of Laboratory Animals of the 
National Institutes of Health. The protocols were approved by the Institutional Animal 
Care and Use Committee at Cornell University (permit number 1995-0057). All 
efforts were made to minimize animal suffering during the course of these studies. 
 
Mice and infections 
Female Swiss Webster mice (6-8 weeks of age) were purchased from the Jackson 
Laboratory (Bar Harbor, ME), and female C57BL/6 were purchased from Taconic 
Farms (Germantown, NY). C57BL/6-Tg(TcraTcrb)425Cbn/J (OT-II) mice were 
obtained from the Jackson Laboratory and maintained as a breeding colony at Cornell 
University College of Veterinary Medicine. The β-catenin Ex3fl/fl mice (43) were 
kindly provided by M. M. Taketo (Kyoto University) were maintained as breeding 
colonies crossed to CD11c-cre expressing mice at the Transgenic Mouse Core Facility 
at the Cornell University College of Veterinary Medicine. Cre+ offspring (Ex3DC-/- 
mice) were identified by PCR amplification of the Cre gene from genomic DNA 
isolated from tail snips. Mouse infections were initiated in 8-12 week old mice by 
intraperitoneal or oral inoculation of 25 cysts of the type II T. gondii ME49 strain. 
Cysts were isolated from chronically infected Swiss Webster mice by homogenization 
of whole brain in sterile PBS.  
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Preparation and purification of leukocytes 
Splenocyte single cell suspensions were prepared by crushing spleens between sterile 
glass slides and filtering the resulting suspension through 40 mM filters. For lung 
leukocytes, lung tissue was minced with sterile razor blades and incubated with 
collagenase type IV (Sigma) in a 37°C water bath for 30 min with frequent agitation. 
The resulting digest was passed through a 40 µM filter to create a single cell 
suspension. Bone marrow-derived DC were cultured as described previously (58). 
Briefly, femurs of C57BL/6 mice were flushed with PBS and cultured for 9 days in 
media containing 10% fetal calf serum (Hyclone), 100 U/ml penicillin (Life 
Technologies), 0.1 mg/ml streptomycin (Life Technologies), 50 µM 2-
mercaptoethanol (Sigma), and 20 ng/ml GM-CSF (Peprotech). A single round of 
positive selection using CD11c+ magnetic bead sorting was performed for purification 
of total splenic DC from single cell suspensions (Stem Cell Technologies), while two-
step magnetic bead sorting, with an initial negative selection to enrich for DC 
followed by CD8α+ positive selection (Miltenyi Biotec), was performed to isolate 
CD8α+ splenic DC. 
 
Western blotting 
To validate nuclear translocation of β-catenin in Ex3DC-/- mice, BMDC were subjected 
to nuclear and cytoplasmic fractionation following the manufacturer’s guidelines 
(Active Motif). Resulting nuclear and cytoplasmic proteins were diluted in reducing 
SDS sample buffer and separated by 10% SDS-PAGE. Separated proteins were 
transferred onto nitrocellulose and blocked for 1 hr at room temperature in Tris-
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buffered saline containing 0.1% Tween-20 and 5% nonfat dry milk (TBST). Following 
3 washes in TBST, blots were incubated overnight in primary antibody diluted in 
TBST containing 5% BSA. Blots were subsequently washed in TBST and incubated 
for 1 hr with anti-rabbit IgG conjugated to horseradish peroxidase-conjugated (HRP) 
diluted in TBST containing 5% nonfat dry milk. Following 5 washes in TBST, blots 
were developed and imaged using a chemiluminescent detection system (Thermo 
Scientific). Anti-β-catenin and anti-PARP were purchased from Cell Signaling, and 
anti-Rab5a was purchased from Santa Cruz Biotechnology. 
 
Flow cytometry 
Single cell suspensions were washed in PBS prior to resuspension in Zombie Aqua 
viability dye (BioLegend) for 15 min at room temperature to exclude dead cells. 
Primary antibodies (anti-CD11c FITC or APC, anti-CD8α Pacific Blue or APC-Cy7, 
anti-CD4 PerCP or FITC, anti-CD205 PerCP, anti-PDCA-1 APC or PE, anti-NK1.1 
APC, anti-CD11b APC-Cy7, anti-CD103 PE, anti-B220 PE) resuspended in ice-cold 
FACS buffer (1% bovine serum albumin/0.01% NaN3 in PBS) were added directly to 
the cells for 30 min. Tetramer staining for Tgd057+CD8+ T cells (provided by George 
Yap, New Jersey School of Medicine and Dentistry) and CD4Ag28m+CD4+ T cells 
(provided by Marion Pepper, University of Washington) was performed by labeling at 
room temperature for 1 hour. For intracellular staining, cells were fixed using the 
FoxP3/transcription factor staining kit fixative (eBioscience) and subsequently 
incubated with primary antibodies resuspended in the FoxP3/transcription factor 
permeabilization buffer (eBioscience). Antibodies used for intracellular cytokine 
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staining include anti-IRF8 PerCP, anti-FoxP3 APC, anti-Ki67 APC, and anti-IRF4 
e450 (eBioscience); anti-β-catenin Alexa-647 (Cell Signaling); and anti-Toxoplasma 
gondii (Argene) For IFN-γ staining, cells were incubated for 4 hrs with Brefeldin-A 
(eBioscience; 10 ug/ml), PMA (Sigma; 10 ng/ml), and ionomycin (Sigma; 1 ug/ml), 
then fixed with the FoxP3/transcription factor staining kit fixative (eBioscience) and 
subsequently incubated with anti-IFN-γ (PE-Cy7; BioLegend). All samples were run 
on an LSRII flow cytometer (BD), and the data were analyzed using FlowJo software 
(FlowJo, Ashland, OR).  
 
Splenic DC BrdU and Annexin labeling 
Mice were injected with 2 mg BrdU (Sigma), and spleens were harvested 4 hours later. 
Single cell suspensions were subjected to BrdU labeling using a FITC BrdU labeling 
kit following the manufacturer’s instructions (BD). For Annexin labeling, cells were 
co-stained for Annexin V (eBioscience) and Zombie Aqua viability dye (BioLegend) 
following the manufacturer’s instructions for the FITC Annexin V kit (eBioscience). 
 
ICG-001 inhibition  
BMDC (1x106) were plated and cultured overnight. The following day, the cells were 
cultured with 5 µM ICG-001 (Selleck Chemicals) or DMSO control for 5 hr at 37°C. 
Cells were surface stained for CD11c, fixed, intracellularly stained for IRF8, IRF4, 
and β-catenin, and analyzed by flow cytometry. Alternatively, RNA was harvested 
from cultured cells, and transcriptional analysis was performed for Irf8 and Axin2 
expression by quantitative PCR. 
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Measurement of mRNA by quantitative PCR 
RNA was isolated from CD11c+ splenocytes magnetically sorted from naïve Ex3DC-/- 
and Ex3fl/fl mice by resuspension in Trizol reagent (Life Technologies). RNA was 
converted to cDNA (Quanta Biosciences, Gaithersburg, MD) and assayed for gene 
expression by SYBR green technology (Quanta Biosciences). Primers were designed 
to span exons by Integrated DNA Technologies. The following primer sequences were 
used: Irf8 Forward, TGCCACTGGTGACCGGATAT; Reverse, 
GACCATCTGGGAGAAAGCTGAA; Nfil3 Forward, 
GAACTCTGCCTTAGCTGAGGT; Reverse, ATTCCCGTTTTCTCCGACACG; Id2 
Forward, ATGAAAGCCTTCAGTCCGGTG; Reverse, 
AGCAGACTCATCGGGTCGT; Batf3 Forward, 
CAGACCCAGAAGGCTGACAAG; Reverse, CTGCGCAGCACAGAGTTCTC; 
Axin2 Forward, TAGGTTCCGGCTATGTCTTTG; Reverse, 
TGTTTCTTACTCCCCATGCG. GAPDH was used as a housekeeping gene. Gene 
expression was normalized to Ex3fl/fl samples or DMSO controls. 
 
Cytokine measurement 
IFN-γ, IL-12p70, and TNF-α secretion were assayed by enzyme-linked 
immunosorbent assay (ELISA) following the manufacturer’s instructions 
(eBioscience) following culture with media or soluble tachyzoite antigen (50 µg/ml) 
prepared as previously described (48). IL-12p40 secretion was measured using an in-
house ELISA (59). 
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Parasite burden measurement 
Levels of T. gondii DNA were measured as described previously (60). Briefly, spleens 
were homogenized, and DNA was extracted using a tissue extraction kit (Omega 
Biotech). The T. gondii B1 gene and the host argininosuccinate lyase (ASL) gene were 
amplified by quantitative real-time PCR, and resulting ct values were compared to 
standard curves developed from 10-fold serial dilutions of parasite DNA and 
splenocyte DNA, respectively. The parasite burden is displayed as the ratio of T. 
gondii DNA to host DNA. 
 
CFSE proliferation assay 
Splenic DC (2x105) purified from Ex3fl/fl and Ex3DC-/- mice by CD11c+ positive 
selection were pulsed with ovalbumin (OVA) for 4 hrs. OVA-specific CD4+ T cells 
were harvested from spleens of naïve OT-II/Rag1-/- mice and labeled with CFSE 
following the manufacturer’s instructions (Invitrogen). CFSE-labeled OT-II T cells 
were then co-cultured with OVA-pulsed DC (2.5:1 T cell : DC) for 3 days. CFSE 
dilution was measured by flow cytometry to assess T cell proliferation. 
 
Statistical analyses 
Differences between groups were analyzed by Student’s t test. A Kaplan-Meier curve 
(Logrank test) was used to calculate differences in survival between Ex3fl/fl and Ex3DC-
/- mice. P values were considered statistically significant at <0.05 and were designated 
*, p<0.05; **, p<0.01; *** p<0.001. 
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Exploring the Role of β-catenin in Splenic and  
Bone Marrow-Derived Dendritic Cells  
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Abstract 
β-catenin has been reported as a negative regulator of dendritic cell (DC) function by 
promoting tolerogenic responses, although most of these studies have been performed 
in vitro using bone marrow-derived (BM) DC. Previous work in our lab has indicated 
a pro-inflammatory role for β-catenin in tissue resident DC in vivo using a transgenic 
model of DC-specific constitutive β-catenin activation. In this study, we sought to 
examine the role of β-catenin in BMDC as compared to splenic DC using this 
transgenic mouse system. We find inverse roles for β-catenin in in vitro-derived 
BMDC and splenic DC, whereby proinflammatory IL-12 secretion is reduced and 
induction of antigen-specific T cell proliferation is abolished in BMDC. Surprisingly, 
phosphorylation of MAPK and STAT mediators was largely unaffected by β-catenin 
activation in BMDC. These results contrast with findings in splenic DC, where 
phosphorylation of p38 and STAT3 was enhanced. However, they corroborate 
previous findings of a tolerogenic role for β-catenin in BMDC and further shed light 
on the DC subset-specific role of this signaling axis in vivo versus in vitro. 
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Introduction 
Dendritic cells (DC) are important sentinels of the immune system that, upon 
recognition of foreign antigen, alert cells of innate immunity to an invading pathogen 
through secretion of pro-inflammatory cytokines while simultaneously presenting the 
antigen to T cells to initiate adaptive immunity. In order to perform these tightly 
regulated processes, DC must respond to foreign antigens through fine tuned signaling 
processes downstream of cell surface receptors, leading to increased expression of 
major histocompatibility complexes, costimulatory molecules, signaling mediators, 
and migration towards lymph nodes (1). A question of immense interest has been how 
DC are able to distinguish between pathogen-derived antigens and self- or commensal-
derived antigens, as improper immune responses against harmless antigens can lead to 
autoimmune diseases, such as inflammatory bowel disease (2, 3).  
 
One recently identified player in the DC-mediated regulation of immunity versus 
tolerance is the Wnt/β-catenin signaling axis. Wnt signaling is generally recognized as 
a regulator of tumorigenesis, as Wnt1, a member of the Wnt gene family, was 
originally identified as an oncogene activated by the genomic insertion of mouse 
mammary tumor virus (4). The pathway centers on β-catenin, a transcription factor 
that is normally kept at low levels in the cytoplasm by constitutive glycogen synthase 
kinase (GSK)-β-mediated phosphorylation and proteasomal degradation. Upon 
binding of an activating Wnt ligand to specific cell surface Frizzled receptors, β-
catenin is released from its degrading complex and is free to enter the nucleus to 
activate transcription of its target genes (5). Wnt signaling has been implicated in 
  173 
controlling numerous cellular functions, including cell cycle, survival, stem cell 
renewal, and body axis polarization (6-10). More recently, β-catenin has been 
implicated in DC immune processes related to tolerance induction. One particular 
groundbreaking finding is that deletion of β-catenin in DC leads to an emergence of 
proinflammatory cytokines and a loss of regulatory T cells in the intestine, implicating 
this signaling axis in dampening inflammatory responses in one of the most antigen 
rich immune compartments in the body (11). Other studies have used in vitro methods 
to demonstrate a tolerizing role for β-catenin, whereby disruption of cell-to-cell 
cadherin complexes or stimulation of DC with Wnt ligands leads to secretion of anti-
inflammatory cytokines (12, 13), and activation or knockdown of β-catenin in bone 
marrow progenitors using targeting vectors promotes or impairs DC maturation, 
respectively (14). Our group more recently identified a striking reverse role for β-
catenin signaling in tissue resident DC, whereby constitutive activation of β-catenin 
leads to expansion of certain conventional DC subsets in dependence on IRF8 
signaling (Cohen et al, Manuscript in Review; See Chapter 4). 
 
Therefore, we sought to compare the role of β-catenin in splenic and bone marrow-
derived (BM) DC using the same transgenic mouse model, in which Exon 3 of the β-
catenin gene is deleted in vivo by a CD11c-driven Cre recombinase, thus 
constitutively activating β-catenin only in CD11c-expressing cells. Most β-catenin 
studies have used non-infectious stimuli, such as LPS, dextran sulfate sodium, or Wnt 
ligands, to investigate the effect of β-catenin on BMDC function (11, 13, 14). 
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Therefore, we included the infectious agent Toxoplasma gondii as a model organism 
for our study. T. gondii is a protozoan parasite that is most often transmitted by the 
ingestion of tissue cysts from undercooked meat. It is a highly prevalent pathogen that 
infects approximately 11% of people in the United States (15) and is a strong inducer 
of IL-12 production, leading to a potent type I inflammatory response (16). 
Furthermore, it has the profound capacity to manipulate host signaling molecules to 
control the outcome of the immune response (17). We therefore wondered whether 
infection with T. gondii would yield similar effects on immunity as LPS following 
constitutive β-catenin activation. 
 
Using both LPS and T. gondii as stimuli, we find that BMDC and splenic DC respond 
differently to constitutive β-catenin activation. Consistent with previously published 
reports, β-catenin signaling in BMDC provides an inhibitory effect on their ability to 
appropriately respond to stimulation, as measured by cytokine secretion and 
upregulation of costimulatory molecules. We further show that β-catenin impairs the 
ability of BMDC to stimulate antigen-specific T cell responses in vitro. However, 
splenic DC with active β-catenin signaling display increased phosphorylation of the 
MAP kinase p38 and STAT3 following stimulation, consistent with our previous 
finding of a pleiotropic role for β-catenin in DC, involving elevated cytokine potential, 
increased regulatory T cell activation, and conventional DC differentiation.  
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Results 
β-catenin activation differentially controls activation and maturation of splenic 
and bone marrow-derived DC 
 
Previous studies in our lab identified a role for β-catenin in promoting inflammation 
by splenic dendritic cells (DC) using a Cre/flox transgenic mouse model of CD11c-
specific β-catenin stabilization (Ex3DC-/- mice), in particular through the expansion of 
CD8α+ DC (Cohen et al, Manuscript in Review; See Chapter 4). This phenotype was 
determined to be a result of IRF8 upregulation, leading to increased IL-12 secretion by 
DC with constitutive β-catenin activation. We next asked if β-catenin contributes to 
the expression of signaling molecules in the mitogen-activated protein kinase (MAPK) 
and signal-transducer and activator of transcription (STAT) families, which are 
involved in the regulation of numerous cellular functions, including cytokine 
production and survival (18-22). To address this, CD11c+ splenic DC were isolated 
from Ex3DC-/- mice and their Ex3fl/fl wild-type (WT) littermate controls by magnetic 
separation, stimulated ex vivo with soluble tachyzoite antigen (STAg), and 
immunoblotted for phosphorylated ERK, p38, and STAT3. There was a small but 
consistent increase in the early phosphorylation of both ERK and p38 upon β-catenin 
activation, but while p38 maintained its phosphorylation status in both genotypes, 
ERK phosphorylation strongly decreased in Ex3DC-/- DC after 1 hr (Figure 5.1). The 
differences between Ex3fl/fl and Ex3DC-/- DC were particularly apparent in the 
unstimulated cells, suggesting that β-catenin may promote phosphorylation of MAPK 
even in the absence of external stimulation. Additionally, STAT3 phosphorylation 
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occurred earlier upon activation of β-catenin phosphorylation and was clearly 
detectable within 15 minutes of STAg stimulation as compared to 30 minutes for WT 
control cells (Figure 5.1). Together these results suggest that β-catenin expression 
enhances phosphorylation of MAPK and STAT family members in splenic DC 
following ex vivo stimulation. 
  177 
 
 
Figure 5.1. Splenic DC with stabilized β-catenin display increased ERK and 
STAT phosphorylation following STAg stimulation. CD11c+ splenic DC were 
magnetically purified from Ex3fl/fl and Ex3DC-/- mice and stimulated ex vivo with 25 
µg/ml soluble tachyzoite antigen (STAg). Lysates were harvested over 3 timepoints, 
and phosphorylation of p38, ERK, and STAT3 were then examined by Western blot. 
Total ERK was used as a loading control. Densitometry was performed to qualitatively 
compare pixel density of bands at each time point. 
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Bone marrow-derived (BM) DC represent a lineage that is distinct from the CD8α+ 
DC found in the spleen (23). Therefore, we next asked whether BMDC display a 
similar activation phenotype upon β-catenin stabilization. To address this, DC were 
generated in vitro from the bone marrow of Ex3fl/fl and Ex3DC-/- mice through addition 
of the growth factor cytokine granulocyte-macrophage colony stimulating factor (GM-
CSF). Upon stimulation of Ex3fl/fl and Ex3DC-/- BMDC with lipopolysaccharide (LPS), 
there were no remarkable differences in the phosphorylation of ERK (Figure 5.2A). 
Furthermore, when the Type II T. gondii Prugniaud strain was used as a stimulus, 
ERK phosphorylation was again equivalent between the genotypes (Figure 5.2A). 
Therefore, β-catenin accumulation in BMDC does not impact ERK phosphorylation 
following in vitro stimulation. 
 
The MAPK p38 is required for NFκB-mediated IL-12 production in response to 
Toxoplasma (18), and STAT3 has been shown to regulate tolerant DC function as well 
as interact with the Wnt signaling pathway(22, 24). Therefore, upregulation of p38 and 
STAT3 phosphorylation were examined in Ex3fl/fl and Ex3DC-/- BMDC following 
stimulation with the Type I T. gondii strain RH. Surprisingly, BMDC from both 
strains displayed equivalent phosphorylation of p38 and STAT3, arguing against a role 
for β-catenin in controlling these signaling mediators (Figure 5.2B). We next 
examined the possibility that STAT1 phosphorylation was affected by β-catenin 
activation, as IFN-γ-dependent signaling is crucial for an optimal immune response 
against Toxoplasma. To address this, Ex3fl/fl and Ex3DC-/- BMDC were stimulated with 
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recombinant IFN-γ, and STAT1 phosphorylation was examined. Early 
phosphorylation was equivalent between the BMDC strains, although there was a 
slight decrease in sustained STAT1 phosphorylation at late timepoints in Ex3DC-/- 
BMDC (Figure 5.2C). While the functional impact of STAT1 phosphorylation was not 
tested, such as induction of IFN-γ-responsive genes, this could suggest a minor 
impairment in STAT1-dependent signaling over time. Examination of costimulatory 
molecule expression following stimulation with STAg provided some additional 
evidence of this impaired activation; although expression levels of CD80 and CD86 
were similar between Ex3fl/fl and Ex3DC-/- BMDC after 3 h, these levels dropped off in 
Ex3DC-/- BMDC by the overnight timepoint (Figure 5.2D).  
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Figure 5.2. Effect of β-catenin stabilization on BMDC activation and maturation. 
(A) Ex3fl/fl and Ex3DC-/- BMDC were stimulated with LPS (100 ng/ml) or the Type II 
T. gondii strain Prugniaud (Pru), and lysates were collected over multiple timepoints 
for analysis of ERK phosphorylation by Western blot. (B) Ex3fl/fl and Ex3DC-/- BMDC 
were stimulated with the Type I T. gondii strain RH over multiple timepoints, and 
lysates were examined for phosphorylation of p38 and STAT3 by Western blot. Total 
STAT3 was used as a loading control. (C) Ex3fl/fl and Ex3DC-/- BMDC were stimulated 
with recombinant IFN-γ (100 ng/ml), and lysates from multiple timepoints were 
assessed for tyrosine phosphorylation of STAT1 by Western blot. (D) Ex3fl/fl and 
Ex3DC-/- BMDC were stimulated with STAg (50 µg/ml), and cells were surface stained 
for costimulatory molecules CD80 and CD86 and analyzed by flow cytometry. 
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β-catenin activation in BMDC impairs IL-12 production 
Since splenic DC with constitutively active β-catenin secrete elevated levels of IL-12 
(Cohen et al, Manuscript in Review; See Chapter 4) and upregulate early p38 
phosphorylation upon stimulation (Figure 5.1), we wondered whether IL-12 
production by BMDC would be affected by β-catenin signaling. Therefore, BMDC 
generated from Ex3fl/fl and Ex3DC-/- mice were cultured with LPS or STAg overnight, 
and IL-12p40 levels in the cell supernatants were assessed by ELISA. Surprisingly, 
considering our earlier results with CD8α+ DC (See Chapter 4), lower levels of IL-
12p40 secretion were observed in Ex3DC-/- BMDC cultures for both LPS and STAg 
stimulations, although the difference in the LPS culture did not quite reach statistical 
significance (Figure 5.3A). To confirm these results, BMDC cultures from Ex3fl/fl and 
Ex3DC-/- mice were stimulated with LPS or the Type II T. gondii strain PTG overnight, 
and Brefeldin-A was added for the last 5 hr of culture to measure intracellular levels of 
IL-12 by flow cytometry. A statistically significant reduction in IL-12 expression was 
observed in Ex3DC-/- BMDC compared to Ex3fl/fl BMDC under both LPS and Pru 
conditions (Figure 5.3B-C). In direct contrast to splenic DC, these results suggest that 
β-catenin expression in BMDC impairs secretion of IL-12 following stimulation, 
consistent with a tolerogenic phenotype in this lineage. 
 
β-catenin stabilization inhibits BMDC-dependent T cell proliferation  
A major role of dendritic cells is to activate T cells in an antigen-specific manner 
through the presentation of processed peptides. To examine the impact of β-catenin on 
the ability of BMDC to stimulate antigen-specific T cell responses, we utilized 
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transgenic T cells that are engineered to express a T cell receptor specific for 
ovalbumin peptide (OVA). Thus, BMDC from Ex3fl/fl and Ex3DC-/- were pulsed with 
OVA and then cultured with CFSE-labeled OVA-specific OT-II T cells to measure T 
cell proliferation. In response to BMDC generated from Ex3fl/fl mice, nearly 40% of T 
cells underwent proliferation as measured by CFSE dilution. By contrast, T cell 
proliferation in response to Ex3DC-/- BMDC was dramatically impaired, as less than 
5% of T cells demonstrated dilution of CFSE (Figure 5.4A). We next examined 
expression of the Th1 transcription factor T-bet following T cell activation by either 
Ex3fl/fl or Ex3DC-/- BMDC. While neither group displayed strong upregulation of T-bet, 
the T cells responding to Ex3fl/fl BMDC demonstrated significantly stronger T-bet 
expression than those responding to Ex3DC-/- BMDC (Figure 5.4B). Foxp3 expression 
was undetectable in T cells responding to either BMDC group (data not shown). 
Analysis of the cytokines in the supernatants from these co-cultures, including IL-12, 
IFN-γ, TNF-α, and IL-17, revealed generally inconsistent results both with regards to 
repeatability and agreement with CFSE results (data not shown). For instance, despite 
impaired T cell proliferation, supernatants occasionally revealed higher levels of IFN-
γ and IL-17 following culture with Ex3DC-/- BMDC, though in repeat experiments this 
result was sometimes reversed. 
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Figure 5.3. IL-12 secretion by BMDC is impaired upon constitutive β-catenin 
activation. (A) Ex3fl/fl and Ex3DC-/- BMDC were stimulated in vitro with LPS (100 
ng/ml) or STAg (50 µg/ml) overnight, and supernatants were assayed for IL-12p40 by 
ELISA. (B) Ex3fl/fl and Ex3DC-/- BMDC were stimulated with LPS or the Type II T. 
gondii strain PTG overnight, and Brefeldin-A was added for the last 5 hr of culture. 
Cells were then intracellularly stained for IL-12 and analyzed by flow cytometry. 
Shown are representative plots from individual samples. (C) Means and standard 
errors of IL-12 production over multiple samples. 
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Figure 5.4. Constitutive β-catenin signaling in BMDC leads to impaired antigen-
specific T cell activation. (A and B) BMDC derived from Ex3fl/fl and Ex3DC-/- mice 
were pulsed with ovalbumin (OVA) peptide and co-cultured with CFSE-labeled CD4+ 
OT-II OVA-specific T cells at a ratio of 5:1 for 96 hr.  (A) Proliferation of CD4+ OT-
II T cells as determined by CFSE dilution was measured by flow cytometry. (B) CD4+ 
OT-II T cells were intracellularly stained for T-bet expression following co-culture 
with Ex3fl/fl and Ex3DC-/- OVA-pulsed BMDC. For A and B, representative FACS 
plots and means and standard errors of multiple samples are shown. 
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Discussion 
Using a transgenic approach of constitutive β-catenin activation in DC, we find that β-
catenin signaling differentially affects splenic DC and BMDC. In splenic DC, β-
catenin signaling led to increased phosphorylation of p38 and STAT3. Despite an 
early increase in ERK phosphorylation, phospho-ERK levels appeared to decline at 
the latest timepoint upon β-catenin activation. p38 and ERK phosphorylation have 
been shown to have inverse effects on IL-12 production, with p38 acting as a positive 
regulator and ERK as a negative regulator (19, 20). STAT3 has pleiotropic roles, as it 
can be activated by IL-10 or IL-6 signaling and has been shown to promote 
tolerogenic responses in DC (22, 25). Therefore, increased p38 and decreased ERK 
phosphorylation may be consistent with earlier findings of elevated IL-12 production 
by splenic DC with constitutive β-catenin signaling. Elevated STAT3 activation may 
relate to the simultaneous capacity of splenic DC with stable β-catenin to promote 
regulatory T cell accumulation (Cohen et al, Manuscript in Review; See Chapter 4). 
Furthermore, STAT3 acts downstream of Flt3L signaling and promotes the 
differentiation of plasmacytoid DC (pDC) through activation of the pDC transcription 
factor E2-2; thus, increased STAT3 phosphorylation in splenic DC by β-catenin 
provides further evidence of its role in promoting tissue resident DC differentiation 
(26, 27). Conversely, β-catenin generally provided a negative impact on BMDC 
maturation and function. Although MAPK and STAT phosphorylation was unaffected 
over a timecourse of stimulation with T. gondii or LPS, IL-12 secretion in response to 
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external stimuli, expression of costimulatory molecules, and activation of antigen-
specific T cell proliferation were impaired in BMDC upon β-catenin stabilization.  
 
While our results are in agreement with other published works that demonstrate a 
potential role for β-catenin in promoting tolerizing signals to BMDC, they highlight an 
apparent contradictory role for β-catenin in simultaneously promoting inflammatory 
responses in tissue resident DC. Therefore, how these in vitro findings relate to DC in 
the in vivo setting becomes less clear. It may be that the role of β-catenin is DC 
subset-specific; despite all expressing CD11c, different DC populations are driven by 
different transcription factors and play different roles during an immune response. For 
example, while CD8α+ DC are resident in the spleen and can therefore elicit a quick 
response to foreign antigen, monocyte-derived DC must be recruited into sites of 
inflammation from the blood and rely on chemokine production by resident cell 
populations.  
 
BMDC are developmentally distinct from other DC lineages, including in vivo CD8α+ 
and plasmacytoid DC (23). In vitro derived cells are artificial by nature, and the in 
vivo equivalent of BMDC grown in the presence of GM-CSF remains obscure. While 
it has been thought that BMDC most closely resemble monocyte-derived DC/TNF-
iNOS producing inflammatory DC (Tip-DC) found in vivo due to similar surface 
marker expression, similar functional characteristics, and their derivation from blood 
monocytes through culture with GM-CSF (28, 29), this theory remains controversial, 
as Tip-DC still develop in mice that lack the receptor for GM-CSF (30). Furthermore, 
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DC-SIGN+ cells elicited following i.p. injection of LPS were presumed to be of 
monocyte origin until it was shown that they were dependent on the conventional DC 
(cDC)-specific transcription factor Zbtb46 and Flt3L, suggesting that they likely 
differentiate independently of monocytes (31, 32). Therefore, direct comparisons of in 
vitro BMDC results to DC results obtained in vivo are difficult and must be 
interpreted with caution. Regardless, many DC Wnt/β-catenin studies have utilized in 
vitro derived DC as a model, and these studies have established a role for Wnt 
signaling in DC maturation and function through transfection or pharmacological 
approaches, including siRNA-mediated knockdown of β-catenin and pathway 
manipulation via Wnt signaling agonists or antagonists (13, 14, 33). Other studies 
have examined the effect of β-catenin signaling in DC using in vivo or ex vivo 
systems, as well (11, 12). However, the overwhelming majority of studies examining 
DC have demonstrated that β-catenin promotes tolerogenic responses as well as DC 
maturation, whether through mechanical disruption of cells or in vitro stimulation with 
Wnt ligands.  
 
As described earlier, DC subsets are equipped with distinct capabilities to combat 
infection and are preprogrammed with different tools to accomplish their tasks. With 
this view, it may not be surprising that β-catenin activation yields disparate outcomes 
depending on the DC subset, as β-catenin target gene promoters may be more or less 
accessible in certain cells than in others. Furthermore, the type of stimulus may play a 
large role in determining the outcome of such studies, as context may affect cross-talk 
between β-catenin and signaling mediators, such as MAPK family members (34).  
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One particular discrepancy in our results is the apparent contradiction that Ex3DC-/- 
BMDC are impaired in IL-12 production in response to stimulation yet appear to 
phosphorylate p38 and ERK normally (Figure 5.2B). The MAPK p38 has been shown 
to regulate IL-12 production by macrophages in response to Toxoplasma and by 
dendritic cells in response to other TLR ligands, while ERK has been shown to 
negatively regulate IL-12 production by DC (18-20, 35). The decrease in IL-12 
production observed in BMDC upon β-catenin activation was fairly minimal, and it is 
possible that changes in p38 and ERK phosphorylation were not apparent due to 
sensitivity restrictions of the Western blot. Future work should examine IL-12 
responses in BMDC at the mRNA level to increase sensitivity. Furthermore, it is 
possible that IRF8 signaling may be more important for IL-12 production in response 
to Toxoplasma than NFκB mediated signals, as has recently been described for DC 
(36). Whether this is true for BMDC grown under GM-CSF conditions is not yet clear, 
but future work should be done to examine IRF8 upregulation in response to 
Toxoplasma in Ex3DC-/- BMDC.  
 
In conclusion, we provide further evidence of an anti-inflammatory role for β-catenin 
in BMDC, whereby constitutive activation of β-catenin renders BMDC unable to 
secrete equivalent levels of IL-12 to wild-type DC or effectively stimulate antigen-
specific T cell proliferation. Considering the published reports of anti-inflammatory 
roles of β-catenin in BMDC, it is surprising that the anti-inflammatory phenotype of 
constitutively active β-catenin was not stronger, particularly with respect to 
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phosphorylation of downstream signaling mediators. This may indicate alternate 
targets of β-catenin for cytokine production or may underscore redundancy that 
prevents unnecessary activation or inhibition of immune responses. 
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Materials and Methods 
Mice and infections  
Mice floxed for Exon 3 of the β-catenin gene (Ex3fl/fl mice) (37) were a generous gift 
from Björn Clausen (Erasmus University) and Aimin Jiang (Roswell Cancer Institute) 
and were established as breeding colonies with CD11c-cre expressing mice at the 
Transgenic Mouse Core Facility at the Cornell University College of Veterinary 
Medicine. Cre expression from all progeny was determined by PCR amplification of 
genomic DNA from tail snips, and Cre+ offspring were designated Ex3DC-/- mice. 
C57BL/6-Tg(TcraTcrb)425Cbn/J (OT-II) mice were purchased from the Jackson 
Laboratory and maintained as a breeding colony at the Cornell University College of 
Veterinary Medicine. Toxoplasma gondii tachyzoites of the Type II PTG and Type I 
RH strains were maintained in vitro through continuous infection and lysis of human 
foreskin fibroblasts cultured at 37°C and 5% CO2. BMDC were infected with 
tachyzoites at a ratio of 3:1 (parasites:DC), spun down at 2000 rpm for 2 min to 
synchronize the infection, and cultured for 24 hr. 
 
Preparation of splenocytes 
Single cell suspensions of splenocytes were prepared by crushing spleens between 
sterile glass slides in ice cold media and passing the resulting suspension through a 40 
µm filter. Red blood cells were then lysed with a brief incubation in ACK lysis buffer 
(Life Technologies).  
 
Generation of bone marrow-derived dendritic cells 
  193 
Bone marrow-derived DC were cultured as described previously (38). Briefly, femurs 
of Ex3fl/fl, Ex3DC-/- mice were flushed with PBS and cultured for 9 days in media 
containing 10% fetal calf serum (Hyclone), 100 U/ml penicillin (Life Technologies), 
0.1 mg/ml streptomycin (Life Technologies), 50 µM 2-mercaptoethanol (Sigma), and 
20 ng/ml GM-CSF (Peprotech). Cells were fed with 8 ml fresh media on days 3 and 6 
and were given 20 ng/ml GM-CSF directly on day 8.  
 
Western blotting 
For analysis of MAPK and STAT phosphorylation, BMDC were lysed in SDS sample 
buffer (106 cells/200 ul buffer) and proteins were separated by gel electrophoresis. 
Separated proteins were transferred onto a nitrocellulose membrane and blocked for 1 
hr at room temperature in Tris-buffered saline containing 0.1% Tween-20 and 5% 
nonfat dry milk (TBST). Blots were incubated overnight in primary antibody diluted 
in TBST containing 5% BSA. Blots were subsequently incubated for 1 hr with anti-
rabbit IgG conjugated to horseradish peroxidase-conjugated (HRP) diluted in TBST 
containing 5% nonfat dry milk. Blots were developed and imaged using a 
chemiluminescent detection system (Thermo Scientific). Anti-phospho-p38, anti-
phospho-ERK, anti-phospho-STAT1, anti-phospho-STAT3, and anti-total STAT3 
were purchased from Cell Signaling. 
 
 
Flow cytometry 
  194 
BMDC were resuspended in ice-cold PBS supplemented with 1% bovine serum 
albumin (BSA) and 10% sodium azide (NaN3). 106 BMDC were then pelleted and 
resuspended in a primary antibody cocktail. Primary antibodies used for surface 
labeling include anti-CD11c FITC, anti-MHCII PE, anti-CD80 PerCP, anti-CD86 
APC-Cy7, anti-CD4 PerCP-Cy5.5. For intracellular IL-12 staining, Brefeldin-A 
(eBioscience; 10 µg/ml) was added during the final 4 hr of a 24 hr culture. For all 
intracellular staining, cells were fixed using the FoxP3/transcription factor fixative 
(eBioscience) and were then incubated with primary antibodies resuspended in the 
FoxP3/transcription factor permeabilization buffer (eBioscience). Antibodies used for 
intracellular staining include anti-IL-12 PE and anti-T-bet APC. 
 
Antigen-specific T cell proliferation 
CD4+ T cells were purified by magnetic separation from the spleens of naïve OT-II 
mice and were labeled with CFSE following the manufacturer’s instructions 
(Invitrogen). Meanwhile, BMDC from Ex3fl/fl and Ex3DC-/- mice were pulsed for 4 hr 
with ovalbumin (OVA) peptide. OVA-pulsed BMDC (105) were then co-cultured with 
CD4+ OT-II T cells at a ratio of 5:1 (T cell:DC) for 96 hr at 37°C. Dilution of CFSE 
was then assessed by flow cytometry as a measure of proliferation.  
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Discussion 
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Summary of findings and future directions 
The immune response to infection must be fine-tuned to efficiently eliminate invading 
pathogens while simultaneously preventing immune-mediated pathology. This 
paradigm is clearly demonstrated by infection with the protozoan parasite Toxoplasma 
gondii, as failure to express proinflammatory cytokines results in overgrowth of 
parasite, yet overexpression of cytokines leads to immune-mediated damage, both 
outcomes resulting in death of the host (1, 2). Achieving this balance involves the 
coordinated action of innate and adaptive immunity that together can successfully 
protect the host from disease. This dissertation aimed to dissect the mechanisms by 
which innate and adaptive immune responses develop and function to combat 
infection with T. gondii.  
In Chapter 3, I presented data demonstrating that chemokine receptor CXCR3 
expression by CD4+ T cells is required for effective clearance of T. gondii from the 
small intestine following oral infection. CXCR3 upregulation enabled appropriate T 
cell recruitment to the small intestine as well as T cell activation, as measured by IFN-
γ expression. As a result of T cell-derived IFN-γ expression, inflammatory monocytes 
present in the gut could become primed to clear the parasite. Indeed, in the absence of 
this chemokine receptor, there were fewer CD4+ T cells in the gut and they were 
impaired in IFN-γ secretion, monocytes failed to upregulate markers of activation, 
such as iNOS and IL-12, and mice succumbed to overgrowth of parasite that was 
limited to the small intestine. Thus, this study underscores the importance of innate 
and adaptive cells cooperating to clear infection, as cytokine from T cells was required 
for innate immune cells to perform antimicrobial effector mechanisms. 
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It has become clear that chemokine-mediated trafficking is more nuanced than simple 
migration from blood into tissue. Rather, chemokine signaling can dictate precise 
locations within tissues, providing a scaffold upon which T cells and antigen 
presenting cells can interact to drive antigen-specific responses (3, 4). While I 
demonstrated a defect in trafficking of total CD4+ T cells to the inflamed intestine in 
the absence of CXCR3, it remains unclear if T cells were also impaired in activation 
due to impaired lymph node interactions or due to intrinsic activation defects. While 
CXCR3 itself is a costimulatory molecule that may provide activation signals to T 
cells (5), another likely possibility is that this receptor controls localization of T cells 
within the tissue microenvironment. Future work should examine the localization of T 
cells in relation to dendritic cells within the tissue by microscopy, as this will help 
determine how CXCR3 may be impacting intercellular interactions and resulting T 
cell activation. 
It also remains unclear how inflammatory monocytes act as effector cells in this 
system. As one of the most frequently infected cells in the intestine (6), it is often 
assumed that monocytes are the primary effector cells to utilize immunity-related 
GTPases (IRG) for parasite killing. While impaired activation of monocytes was 
strongly associated with increased parasite burden in the absence of CXCR3, it would 
be interesting to formally address the role of IRG proteins in parasite killing by 
intestinal monocytes. This could be done through imaging experiments to monitor 
expression levels of IRG by infected cells in the intestine or by genetic experiments to 
create monocyte-specific IRG deletions and see if parasite burden is affected. 
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In Chapter 4, I made the unexpected discovery that constitutive activation of β-
catenin signaling in CD11c+ dendritic cells (DC) (Ex3DC-/- mice) led to the expansion 
of tissue resident DC that matched the signature of interferon regulatory factor (IRF) 
8-dependent subsets, including splenic CD8α+ DC, plasmacytoid DC, and non-
lymphoid tissue CD103+ DC. Indeed, IRF8 was strongly upregulated among these DC 
subsets following β-catenin accumulation. Furthermore, DC from Ex3DC-/- mice were 
highly proinflammatory and secreted large amounts of IL-12 following stimulation 
with LPS or Toxoplasma antigen. As a result, infection of Ex3DC-/- mice with a 
normally non-lethal dose of T. gondii led to severe susceptibility at the acute phase of 
disease.  
This phenotype was surprising, as other groups have found dendritic cell-derived β-
catenin to drive an anti-inflammatory phenotype, in part through the induction of Treg 
(7-10). Consistent with previous findings, I also observed increased Treg as a result of 
constitutive β-catenin signaling in Ex3DC-/- mice, yet Toxoplasma infection results in 
their disappearance, rendering them non-functional (11). We believe that through this 
unique attribute of diminishing Treg numbers, T. gondii infection revealed a 
previously ensconced proinflammatory outcome of β-catenin signaling. This raises 
questions of how universal this proinflammatory phenotype is or whether it is specific 
to T. gondii infection, where expanded Treg cannot protect from disease. Future 
studies should aim to address this question through use of other inflammatory models, 
such as DSS colitis or experimental autoimmune encephalitis, both of which have 
been shown to require functional Treg for prevention of pathology (12, 13).   
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Another future goal of this project is to demonstrate a molecular interaction between 
β-catenin and IRF8 at the Irf8 promoter. The results from this study suggest a direct 
effect of β-catenin signaling on IRF8 upregulation, as constitutive β-signaling led to 
increased IRF8 expression, which could be blocked at the mRNA and protein level by 
β-catenin inhibition. One possibility is that this is due to direct binding of β-catenin to 
Tcf/Lef sites within the Irf8 promoter. Chromatin immunoprecipitation studies should 
be performed to address whether β-catenin or Tcf/Lef transcription factors are indeed 
enriched at the Irf8 promoter.  
One concern with the transgenic mouse model used in this study is the fact that CD11c 
is not entirely specific for dendritic cells. Thus, β-catenin may also be stabilized in 
monocytes, a subset of natural killer cells, and some T cells when using a CD11c-
driven promoter. To avoid this issue, an interesting approach would be to delete exon 
3 of β-catenin using a promoter driven by Zbtb46, a transcription factor that was 
recently found to be specific for conventional DC (14, 15).While this would exclude 
plasmacytoid DC as they are not conventional DC, it would allow us to focus on the 
role of β-catenin on CD8α+ DC. 
In Chapter 5, the effect of constitutive β-catenin signaling was compared between 
bone marrow-derived DC (BMDC) and splenic DC. Despite a clear proinflammatory 
role for β-catenin signaling in splenic DC as observed in Chapter 4, this study 
identified an anti-inflammatory role in BMDC. As such, BMDC stimulated with LPS 
or Toxoplasma secreted decreased levels of IL-12 and failed to induce proliferation of 
antigen-specific T cells. Surprisingly, there were minimal changes in the 
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phosphorylation of downstream signaling mediators, including ERK, p38, and STAT3, 
upon β-catenin activation. Future studies should examine other mediators that may be 
affected by β-catenin signaling, including NFκB. One potential mechanism of β-
catenin-induced tolerance is through modulation of FOXO3 expression (16); thus, 
future studies could examine the effect of constitutive β-catenin expression on FOXO3 
levels. Other pathways of DC tolerance can also be investigated, such as expression of 
the tryptophan degrading enzyme indoleamine dioxygenase (IDO), retinoic acid 
metabolizing enzymes, or inhibitory surface markers, such as CTLA-4 (17-19). 
Overall, this thesis highlights the important roles of both CD4+ T cells and CD8α+ DC 
during infection with the protozoan parasite Toxoplasma gondii and introduces 
CXCR3 as a previously unidentified player in protective intestinal immunity and β-
catenin as a novel regulator of DC subset differentiation. Furthermore, the data 
presented here underscore the complexity of immunity during microbial infection as 
well as at the steady state. Many questions remain unanswered, paving the way for 
future investigations.  
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